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INTRODUCTION 
H1stomonas meleagridis is the etiologic agent of an acute 
fatal disease of turkey poults known as infectious entero-
hepati tis or histomonosis. The disease is characterized by 
the development of caseonecrotic typhlitis and focal necro-
tic hepatitis. Mortality is high in untreated cases. Use of 
dimetridazole, an anti-histomonal drug, results in remission 
of clinical signs and lesions and birds so treated are sub-
sequently highly resistant to challenge with virulent histo-
monad.s . In these birds, the characteristic residual tissue 
change is the presence of numerous foci of lymphoid cells in 
the liver and cecal necks. 
Immunization with attenuated. cultures of histomonads 
establishes partial protection apparently expressed in cecal 
mucosa . This protection is easily broken down by challenge 
with embryonated Heterakis gallinarum eggs known to produce 
histomonosis. Precipitating and complement-fixing antibodies 
are demonstrable in sera from clinically ill and. immune-
recovered birds but transfer of such sera does not confer 
any protection to susceptible birds. 
The nature of immunity established in birds that recover 
from the disease spontaneously or as a result of drug therapy 
is incompletely understood. However, the presence of large 
numbers of lymphoid cell accumulations in the liver and ceca 
in immune recovered birds suggests that these eel · s may be 
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involved in mediation of immunity which is established in 
these birds. 
This study was designed to investigate the response of 
recovered immune birds to challenge with virulent histomonads 
after these residual lymphoid foci have been destroyed by the 
use of nitrogen mustard, a chemical immunosuppressant agent . 
It is believed that knowledge obtained from this study will 
serve as a basis for future studies involving identification 
and transplantation of specific cells involved in immunity 
to this protozoan disease. 
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REVIEW OF LITERATURE 
Histomonosis or infectious enterohepatitis is a proto-
zoan disease of many gallinaceous birds. In the turkey, it 
is an acute disease with a high mortality rate. Smith (1895) 
reported the disease in turkeys and attributed it to a proto-
zoan parasite which he named Amoeba meleagridis. The organ-
ism was later reclassified in Zoomastigina as His t omonas 
meleagridis by Tyzzer (1920) after he studied its pleomorphic 
nature and determined that it was a flagellate. Since then, 
the disease has been extensively studied by several investi-
gators with regard. to etiology (Bradley and Reid, 1966; 
Goedbloed and Bool, 1962; Kemp and. Reid, 1966b; Tyzzer, 1920, 
1927, 1932 , 1934a; Tyzzer and. Collier, 1925; Tyzzer and 
Fabyan, 1922) and transmission (Graybill and Smith , 1920; 
Horton- Smith and Long, 1956; Lund and Burtner, 1957; McGuire 
and Morehouse, 1958; Tyzzer and. Fabyan, 1920) . It is gen-
erally agreed that Histomonas meleagridi s is the etiologic 
agent of the so-called "blackhead'' or inf ectious enterohep-
ati tis of turkeys . 
Graybill and Smith (1920) produced the disease in the 
turkeys by feeding them embryonated. He t e r akis gall ina rum eggs . 
Two years later, Tyzzer and Fabyan (1922 ) clearly demonstrated 
the transm1ss1on of H1stomonas meleagr1d1s by Heterakis ova 
and this finding was later substantiated by other workers 
(Gibbs, 1962 ; Lund. and Burtner, 1957; McKay and Morehouse , 
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194?). Lund et al. (1966) provided conclusive evidence show-
ing that earthworms are biologic vectors for Heterakis gall-
inarum. Poultry may acquire the disease (histomonosis) by 
ingesting embryonated Heterakis gallinarum eggs provided 
these eggs are harboring virulent histomonads . 
The disease has been extensively studied with respect to 
pathogenesis and development of the lesions (Clarkson, 1962 ; 
Farmer et al., 1951; McGuire and Morehouse, 1958; Malewitz 
et al ., 1958). Infection is thought to start in the ceca 
where the initial response is characterized by hyperemia, 
leukocytic infiltration of submucosa and thickening of the 
cecal wall. There is sloughing of cecal epithelium . Later 
a caseonecrotic core forms in the cecal lumen . Rupture of 
the capillaries allows histomonads to enter the liver via 
the hepatic portal veins (Clarkson, 1962; McGuire and More-
house, 1958). Once in the liver, histomonads continue to 
multiply and destroy much of the parenchyma . The affected 
birds finally die due to loss of functional liver tissue, 
dehydration, and inadequate feed consumption. Histological 
examination of turkeys that die from the disease shows a 
severe caseonecrotic typhlitis and a multiple focal necroti c 
hepatitis . Birds that recover from the disease naturally or 
as a result of drug therapy show numerous lymphoid foci in 
both the ceca and liver . 
Doll and Franker (1963) were unable to induce histomono-
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sis 1n bacteria-free turkeys and suggested that the patho-
genesis and development of lesions seen 1n this disease may 
be due to a combined action of Histomonas and the normal 
intestinal flora. Franker and Doll ( 1964) produced. the 
disease in previously bacteria-free hosts by administering 
certain of the normal bacterial species along with histo-
monad.s. Bradley and. Reid. ( 1966) were unable to induce the 
di sease in turkeys using Histomonas meleagridis in the ab-
sence of E. coli and suggested a dual etiology involving 
a protozoan (H. meleagridis) and a bacterium (~. coli) for 
histomonosis . 
Some of the host responses to the disease have been 
partially characterized by several investigators. Johnson 
and Lange (1939) studied blood smears from experimentally 
infected turkeys and compared these results with those they 
had obtained from a study of natural cases. In b oth in-
stances, blood cell alterations were similar. They reported 
finding a marked heterophilia which appeared 24 hours post-
infection and. persisted until death of t he birds. Infected 
birds also showed a myelocytos1s and anemia in terminal stages 
of the disease . 
McGuirA and Cavett (1952) reported a progressive in-
crease in total leukocyte count beginning with the appearance 
of "early clinical signs" and continuing throughout the course 
of the diseas.e. There was a sixfold. increase in the number 
of heterophiJs just before death. Lymphocytes in~reased early 
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in the course of the disease but began to decrease rapidly as 
the disease progressed. 
Malewitz and. Calhoun (1957) studied blood. cell response 
of the infected turkeys and reported that those that eventu-
ally died from infection showed a persistent het~rophilia 
and. lymphopenia. They did not find any significant changes 
in monocyte, eosinophil, or basophil counts. They also re-
ported a drop in hemoglobin levels and lowered total erythro-
cyte count. 
Bierer (1969) analysed turkey serum and extaolished that 
the usual normal serum protein fractions were present. Al-
terations in serum protein values of histomonas-infected. 
turkeys were reported by Clarkson (1959). He found that 
serum gamma globulins increased fivefold while serum albumin 
levels fell to approximately one-half the normal level. 
Clarkson (1966) attempted to correlate serum protein changes 
in histomonas- infected poults with pathological changes ob-
served in the liver and ceca. He suggested that the escape 
of albumin from inflamed ceca into the cecal lumen resulted 
in the initial fall in serum albumin level. Further re-
duction in albumin, noted later in the disease, was attri -
buted to th~ inability of the damaged liver to adequately 
produce albumin. He also suggested that "either an immuno-
logic response" and/or "a non-specific response to tissue 
damage" acco.mted for the rise in gamma globulinr:. 
Histomoaosis has also been studied in chickens, a species 
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in which the disease generally tends to run a milder course. 
Venkataratnam and Clarkson (1963) studied alterations in 
blood cell response of chicken infected with Histomonas mel-
eagridis and observed an increase in the total number of 
leukocytes from J0,000 to 70,000 cells/cu. mm., 10 days post-
infection. This rise was chiefly because of an increase in 
total number of heterophils and lymphocytes. Eosinophils 
and monocytes were also increased but no significant changes 
were observed in either total erythrocytes or basophil counts. 
All counts had returned to within normal range by 21 days 
postinfect1on. Histopathologic studies of the involved 
tissues revealed that lesions in both ceca and liver coin-
cided with increases in heterophil response in tissues and 
peripheral blood while lymphocytes, monocytes , and eosinophils 
were most prominent in the recovery phase. 
Serum protein changes in histomonas-infected chickens 
have been partially investigated (Beg and Clarkson, 1970; 
McDougald and. Hansen, 1969). Serum albumin levels tended to 
fall early in the course of the disease but returned to near 
normal levels as the lesions resolved. Total globulin levels 
increased during the course of the disease and were signifi-
cantly higr9r than in the control birds, 12 days postinfection 
(McDougald. and Hansen, 1969). Beg and Clarkson (1970) found 
marked increases primarily in gamma globulin levels. 
Serum e.!lzyme changes associated. with the di1:..ease have 
been reported by McDougald and Hansen (1970) . Trese workers 
8 
found. significant increases in both lactic dehydrogenase and 
serum glutaJilic oxalacetic transaJilinase (SGOT) in histomonas-
infected turkeys and chickens. Increases in enzyme levels 
correlated with tissue breakdown in the liver and ceca. 
McGuire and Cavett (1952) reported on changes in blood 
uric acid content and non-protein nitrogen during the course 
of the disease. The level of blood uric acid dropped early 
in the course of the disease, returned to near no1·mal as the 
clinical signs became severe, and was markedly elevated in 
the terminal stages of the disease. Non-protein nitrogen 
values decreased as the disease progressed except on the day 
of death when the values were near normal. 
Several workers have contributed to the study of histo-
monosis immunity . Tyzzer (1932, 1934b, 1936) used culture-
attenuated strains of histomonads in his immunity studies of 
the disease. He found that he could establish only partial 
protection, since challenge with a virulent strain of histo-
monads produced the disease. 
Lund (1959) challenged turkeys which he had immunized 
with a non-pathogenic strain of Histomonas and obtained var-
iable results. These turkeys were refractory to the disease 
when challenged by intra-rectal inoculation of histomonads 
but this resistance broke down when it was challenged by means 
of embryonated Heterakis eggs. From these fi ndings he sug-
gested that ~in immune component was established en the surface 
of cecal mucosa, but was not effective against migrating 
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HeteTakis larvae, which penetrated the epithelium. 
Ruff and Hansen (1970) have shown that use of gamma-
irradiated histomonads does not confer solid i mmunity to 
susceptible turkeys. 
Several investigators have studied the i mmunity in tur-
keys that had recovered from the disease a fter drug therapy . 
Swales (1950) found that birds developed resistance to rein-
fection if treatment with 2-amino-5-nitroth iazole (Enheptin-
T) was instituted after early cecal lesions had developed 
while complete suppression of early cecal lesions left these 
birds susceptible to reinfection . Kendall (1957 ) found that 
turkeys which recovered fro m experimental infecti on after 
sodium acetarsol therapy resisted reinfection. Clarkson 
(1963) reported that chickens that spontaneously recovered 
from the disease and turkeys that recover ed from infection 
after acinitrazole (Entramin A) therapy developed "protective 
i!'.IlIIlunitY". Clarkson (1966 ) suggested t hat i mmuni zation 
against histomonosis was best accomplished by initiating 
chemotherapy after the disease was well established in the 
cecal mucosa. 
Precipitating antibodies are detectable in Histomonas-
infected birds and in immune, recovered birds ( Clarkson, 1963), 
but attempts to immunize susceptible bi r ds by means of whole 
blood or serum transfer (Clarkson, 1963) have failed to confer 
any protecti ve i mmunity. 
Pertinen t information on some of t he immune mechanisms 
10 
in avian species has come from studies of cecal coccidiosis. 
Protective immunity develops in chickens that recover from 
Eimeria tenella infection. Work by Burns and Challey (1959) 
and Horton-Smith et al. (1961) demonstrated that resistance 
to cecal coccidiosis could be transferred from an infected. 
cecum to a previously isolated and uninfected cecum, pre-
sumably via the circulation. Leathern and Burns (1967) point-
ed out that while sporozoites of Eimeria tenella are capable 
of invading cecal mucosa of immune birds, their developmental 
stages are suppressed. Tyzzer (1929) and Pierce and Long 
(1965) were unable to transfer protective immunity from birds 
immune to Eimeria tenella infection to susceptible chickens 
by means of blood or serum. However, Rose (1971) has in-
dicated that serum taken from birds infected. with Eimeria 
maxima wi ll protect susceptible chickens. She points out 
that, transfer of large quantities of serum between days 
14 and 21 postinfection offers the best protection . 
When immune birds are chall enged, the characteristic 
tissue r esponse is massive infiltration of cecal submucosa 
by "pyr oninophilic cells" which resemble plasma cells 
(Horton- Smith, 1963). The glandular crypts and surrounding 
connective tissue are heavily infiltrated by heterophils . 
I mmunity established by Eimeria tenella infection is species 
specific (Rose and. Long, 1962; Tyzzer, 1929). Evidence pre-
sented by Pierce and Long (1965) suggests that acquired im-
munity to cecal cocoidiosis is largel y cellular r a ther than 
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hum.oral in nature since destruction of the bursa of Fabricius 
without destroying the thymus does not appear to significant-
ly influence the response to challenge. 
Although whole bod.y irradiation, immunosuppressive d.rugs, 
thymectomy, and bursectomy have been used. extensively in a 
variety of studies on the immune responses of the chicken 
(Cooper et al., 1966; Dent and. Good., 1965; Glick et al., 1957; 
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Graetzer et al., 1963; Jankovic and Isakovic, 1966; Lerman 
and Weidanz, 1970; St. Pierre and. Ackerman, 1965; Warner and 
Szenberg, 1962; Warner et al., 1962; Weber and Weidanz, 1969), 
few investigators have utilized these techniques i n the study 
of immune response to protozoan infections. Stud.l as by 
Farmer and Breitenback (1968) and Longenecker et al. (1966) 
indicate that burs~otomy lowers resistance to Plasmodium 
lophurae infections in chicken. 
The immunosuppressive property of nitrogen mustard is 
due to its cytotoxic activity on all rapidly dividing cells 
in the body with the primary action probably being the 
alkylation of nucleic acids, thus blocking replication and 
cell division. However, lymphocytes tend to be more sensi-
tive to the action of mechlorethamine than do any of the cells 
of the granulocytic series (Calabrensi and Parks, 1970). 
Taliaferro and. Taliaferro ( 1948) reported that admin-
istration of nitrogen mustard to chickens lowered their 
acquired immunity to malaria infections. Similar immune 
suppression had been reported by Philip et al. (1947) in 
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immune goats. Seto and Henderson (1968) used nitrogen mustard 
and irradiation to suppress immune responses of yoting chickens 
to mammalian erythrocytes and obtained comparable results 
with the two techniques . 
Suppress i on of immune responses of Histomonas-inf ected 
turkeys were partially investigated by Kemp (1970). He 
found that birds which had been treated with mechlorethamine 
HCl either developed less severe or no lesions . The histo-
pathologic alterations in the liver consisted of coagulation 
necrosis with minimal inflammatory reaction. Numerous hi~to-
monads wer e present in the liver and ceca. Total leukocyte 
count was markedly depressed and survival time was longer in 
these birds than in the infected control group. A suggestion 
that "normal host inflammatory response to histomonads in the 
liver may contribute to the virulence of the d.isease" was 
advanced. 
The drug, 1,2-dimethyl-5-nitroimidazole (d.ime tridazole), 
is an effective cure for histomonosis (Joyner et al . , 1966; 
J.M.S . Lucas et al ., 1961, 1962, 1963; McGuire et al., 1964), 
even when treatment is delayed until both cecal a nd liver 
lesions have developed (Morehouse et al., 1968). 
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MATERIALS AND METHODS 
Trial I 
Source and ~ of animals 
Twenty-five Williams broadwhite day-old poults used in 
1 this trial were purchased from a commercial hatchery. They 
were wing-banded for identification and maintained in a 
brooder battery for the first 3 weeks before being trans-
ferred to a growing battery where they were kept throughout 
the course of the experiment. All birds were maintained ad 
libitum on a commercial, non-medicated starter ration, and 
water. 
Initial infection with Heterakis gallinarum ~ 
At 7 days of age, each poult was given ~ os approx-
imately 500 embryonated Heterakis eggs from a stock that had 
been shown to induce fatal histomonosls in susceptible 
turkeys . This dose served as the initial immunizing infec-
tion. 
Weights 
All birds were weighed each tlme prior to collection of 
blood samples. 
1 Jerome Turkey Hatchery, Inc ., Barron, Wisconsin. 
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Collection of blood samples, total and differential leukocyte 
counts 
Starting on the 7th day postinfect1on approximately 1 
ml. blood was collected from each poult twice weekly through-
out the course of the experiment. Disposable tul:erculin 
syringes were used to collect blood from the jugular vein. 
Blood was immediately transferred into 12 by 75 nun. glass 
tubes. A drop of blood from each sample was used for leuko-
cyte and differential counts. Total leukocyte counts were 
estimated using the Rees-Ecker Method as reported by Lucas 
and Jamroz (1961). The total number of cells counted from 
the four corner squares of a hemocytometer counting chamber 
were multiplied by 50 to give the total leukocyte count per 
cubic millimeter. Slide smears were air-dried and stained 
with standard Wright's Stain for differential leukocyte 
counts. Myelocytes were counted as heterophils. 
Collection of serum samples 
Approximately 1 ml. of the blood sample collected was 
allowed to stand (in tubes) at room temperature for 1 hour or 
until the clot had retracted.. The blood was centrifuged at 
2000 r.p.m. for 20 minutes. By means of Pasteur pipettes, 
serum was removed from the clot and placed in evacuated, sili-
cone-coated glass tubes1 provided with rubber stoppers. 
111B-D Va cuta1ners", Becton-Dickinson and Co., Columbus, 
Nebraska. 
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The serum was kept frozen until total serum protein, 
serum protein fractions and serum glutamic oxalacetic trans-
aminase (SGOT) determinations were made, usually 1-J weeks 
later. 
Treatment with 1.2-dimethyl-2-nitroimidazole 
Poults were observed daily for any clinical signs of the 
disease. After the disease was well established in the liver, 
as indicated by passage of "sulfur-yellow" droppings, each 
poult was treated with an oral dose of the drug, 1,2- dimethyl-
5-nitroimidazole (Dimetridazole)l, at the rate of 62.5 mg/ kg. 
Daily observations were continued until all the bird.s appear-
ed to have recovered. Passage of normal droppings and the 
apparent return of total leukocyte counts to within the normal 
range, were taken as indicators of recovery . Poults that 
died during this period were necropsied. Gross observations 
of the tissues were made and results were recorded . Tissues 
from these necropsies were fixed in 10% buffered formalin and 
saved for further processing for histopathol ogic s t udies. 
Fifteen recovered birds were divided into 3 groups, of 
5 birds each , as follows: 
Group 1 - Immune control birds. 
Group 2 - Heteraki s-egg challenged birds. 
Group 3 - Chemical immunosuppression followed by challenge 
with He terakis eggs . 
1Dimetr1dazole was ki nd ly donated by Dr. T . A. Rude, from 
Salsbury Lab0ratories, Charles City, Iowa . 
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Administration of an immunosuppressant --
After recovery, each of the poults in Group 3 received 
intravenous mechlorethamine-IICl, Methylbis(-Chloroethyl) -
amine HCl 1 , (HN2) at the rate of 1 1/3 mg/kg. every 3rd d.ay 
for 2 weeks . 
Challenge with embryonated Heterakis ~ 
Ten days after administration of the initial dose of 
mechlorethamine-HCl to poults in Group 3, poults in Groups 2 
and 3 were challenged with an oral dose of approximately 500 
Heterakis eggs obtained from the same culture stock that was 
used for initial immunization infection. These 2 groups were 
kept in cages below that hold.ing Group 1. This housing 
arrangement was designed. to minimize possible reinfection of 
Group 1 by Groups 2 and J, through contamination. 
Necropsy examination 
Birds that died during the course of the experiment were 
necropsied. All surviving birds in the 3 groups were necrop-
sied 25 days after administration of challenge dose. Gross 
lesions were d.escribed and. the following tissue samples were 
fixed in 10~ buffered formalin and saved for further process-
ing for h1stopathologic studies: 
Myocardium 
Lung 
1Methylb is(-Chloroethyl )-amine HCl by Pfaltz and Bauer, 
Inc. 
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Liver 
Kid.ney 
Spleen 
Bursa of Fabrioius 
Ceca 
Small Intestine 
Serum protein determination 
Total serum protein values for each serum sample were 
determined by the Goldberg refractometer method. Actual 
values expressed in gm/100 ml. were read directly from AO/TS 
Meter, Model 104001 • 
Serum glutamic oxalacetate assay 
Serum samples which had been frozen were allowed to thaw 
at room temperature. Each sample was divided into aliquots. 
One portion was used for serum electrophoresis and the other 
was diluted with distilled water. The latter portion was used 
in 1: 6 d.ilution for SGOT assay. The enzyme was assayed by the 
colorimetric method. of Reitman and Frankel ( 19 57) • Procedure 
and reagents as outlined in Sigma Technical Bulletin No . 5052 
were used for the test. A Coleman, Junior Model 6A Spectro-
photometer3 at 505 mu. was used for all readings . SGOT levels 
1American Optical Instrument Company, Buffalo, N.Y . 14215 
2sigma Chemical Company, St. Louis, Missouri. 
3coleman Instruments, Inc ., Maywood , Illinois. 
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were expressed in Sigma-Frankel units/ml. of serum. 
Serum electrophoresis 
Serum electrophoretic separations were done on cellulose 
acetate electrophoresis membranes. A freshly prepared, high 
resolution barbital buffer. pH 8.6 with an ionic strength of 
0.075, was used. Electrophoretic separation was carried out 
at a constant voltage of 250 V and 15-20 mA for 1 hour in a 
Brinkmann electrophoresis chamber1. The membranes were stain-
ed in Ponceau-S-dye2 , decolorized in 5% acetic acid, dehy-
drated in ethanol, cleared, and. dried. These cleared mem-
brane strips were later scanned. on a recording densitometer/ 
integrator3. The concentration of each serum fraction was 
expressed as grams per cent of total and. as a relative per 
cent of the total serum protein. 
Preparation of tissues for histopathologic studies 
All tissues were prepared for sectioning by the stand.ard 
ethanol dehydration and paraffin embed.ding techniques. The 
routine stain used was hematoxylin and eosin. Selected. 
tissues were also stained with the periodic acid-Schiff (PAS) 
1Brinkmann Instruments, Inc., New York, N.Y. 
2 Ind.ustrial Chemicals Division, Morristown, N.J. 
3Gelman Instruments Company, Ann Arbor, Mich. 
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technique f or better visualization of histomonads (Kemp and 
Reid, 1966a) . 
Trial II 
In this trial, 25 poults were purchased a s d.a.y old 
poults from the same source as those used in Trial I . Exper -
imental procedures were similar to those of Trial I with few 
exceptions . Thirteen recovered birds were divided into 3 
groups as follows: 
Group 1 - Immune control birds (4 birds) . 
Group 2 - Heterakis-egg challenged birds (4 bird s) . 
Group 3 - Chemical immunosuppression and challenge with 
Heterakis eggs (5 birds). 
In this trial the immunosuppressant, HN2 , was given to Group 
3 on the same day that Groups 2 and 3 were challenged with 
embryonated. Heterakis eggs as opposed to Trial I in which 
immunosuppression was started 10 days prior to challenge . The 
dosage was also increased from 1 1/3 mg/kg . every J days to 
4 mg/kg. and was given on days 0, 4, and 9 postchallenge . 
Trial III 
Twenty- nine poults in this trial wer e purchased as day-
old poults from Thompson Hatchery, Ellsworth , Iowa. Care of 
animals and handling of blood samples were similar to that in 
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Trials I and II . However, the mechanics of this trial 
varied slightl y from those of previous trials. The timing 
of HN2 administration was altered in order to deter mine if 
this would make any difference in the immunosuppressive 
effects already detected in Trials I and II. Birds in Trial 
III were divided into 5 groups as follows: 
Group 1 - Consisted of 5 uninfected control birds. 
Group 2, 3. and 4 - Nineteen birds which had been infect-
ed, treated, and recovered were ar b itrarily 
divided into 3 groups of 6, ?. and 6 birds each, 
respectively . 
Group 2 - Birds in this group were later challenged 
with Heterakis eggs. 
Group 3 - Each bird in this group was given HN2. 
intravenously, at the rate of 1 1/3 
mg/kg/day for 5 days starting 2 days be-
fore challenge. 
Group 4 - Birds in Group 4 were not given HN2 until 
7 days postchallenge . Dosage and duration 
of treatment were identical to those used 
in Group J. 
Group 5 - Which consisted of birds that had not been pre-
viously infected, was infected at the time of 
challenge. This group served as the infected 
control group. 
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At challenge, all birds in Groups 2, J, 4, and 5 were 
infected per 2§. with approximately 50 0 Heterakis eggs/bird 
from the origi nal culture. 
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RESULTS 
Trial I 
Mortality 
Mortality in Groups 1, 2 , and J were 2/5, 1/5 , and J/5. 
respectively. 
Body Weights 
Data for body weights of different groups ar e given in 
Table 1. There were no significant differences wi th regard 
to weight gains a mong all groups until a few days after chal-
lenge when birds in Group J began to lose weight (Figure 1). 
Hematologic Observations 
Total leukocyte counts 
Detailed results of the total leukocyte counts for the 
J groups are summarized in Table 2 . The typical l eukocyte 
r esponse in all groups was an i nitial leukocytosis which was 
quite marked 12 to 14 days postinfection . This wa s followed 
by a g radual decrease in leukocytes after treatment with 
dimetridazole and the counts soon f ell to within the normal 
range (Figure 2). The total leukocyte numbers in Group 2, 
r ose after challenge with Heterakis eggs and remained 
slightly above control values (Group 1) for the remainder 
of the trial period . Leukopenia developed i n Group J while 
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Table 1. Comparison of average weights (in grams) of three 
groups of turkeys during the experimental peri od 
Days Post- Group Numbers 
infection 1 2 J 
7 115 (5)a 126 (5) 116 (5) 
12 126 (5) 145 ( 5) 1J2 ( 5) 
15 157 (5) 179 (5) 161 (5) 
19 192 (5) 221 (5) 200 (5) 
22 228 (5) 263 ( 5) 236 (5) 
26 304 ( 5) 344 ( 5) 305 (5) 
JO 372 (5) 434 ( 5) 360 (5) 
33 498 ( 4) 592 ( 5) 426 (5) 
35 531 (4) 644 ( 5) 416 ( 5) 
40 669 ( 4) 857 ( 4) 514 (4) 
44 729 ( 4) 959 (4) 635 (2) 
47 957 (3) l,1J2 ( 4) 780 ( 2) 
50 1.098 ( J) 1.224 ( 4) 881 (2) 
54 1,166 ( 3) 1,181 ( 4) 767 ( 2) 
57 1,227 (J) 1,193 ( 4) 727 ( 2) 
aTotal number of birds used. 
Table 2 . Comparison of average total leukocyte counts of 
three groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
infection 1 ~ 2 
7 19 , 600 (5)a 2 7. 000 ( 5) 25 ,050 ( 5) 
12 54,550 (5) 48 ,250 ( 5 ) 55 . 500 ( 5) 
15 32.750 (5 ) 46,600 ( 5) 40, 800 (5) 
19 22,750 ( 5 ) 26.700 ( 5) 19,00() (5) 
22 19,250 ( 5) 32,750 ( 5) 25,300 (5) 
26 19.400 ( 5) 17'850 (5 ) 23,250 (5) 
JO 15,650 ( 5 ) 17,300 ( 5) 12,050 (5) 
33 24.650 ( 4) 19,900 (5) 10,450 (5) 
35 22,900 ( 4) 14,550 (5) 5,000 (5) 
40 26 , 850 ( 4) 17,950 (4) 2,500 ( 4) 
44 38,650 (4) 25,500 ( 4) 800 ( 2 ) 
47 26, 884 ( 3) 24,450 ( 4) 850 (2) 
50 25 , 300 ( 3) 41,400 ( 4) lJ, 000 ( 2) 
54 23,050 (3) 43.900 (4) 54,850 (2) 
~z JJ.900 ( 3) 50,600 (4) z2,2so (21 
aTotal number of birds used. 
Figure 1. Progressive changes in the body weights of the following groups in 
Tr i al I : 
Group 1 - Immune-control . 
Group 2 - Immune-challenged. 
Group J - HNz-treated. 
Infection at 7 days of age 
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Fi gure 2 . Total leukocyte response pattern of the following groups in Trial I: 
Group 1 - I mmune- control . 
Group 2 - I mmune- challenged . 
Group 3 - HN2-treated . 
I nfection at 7 days of age 
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birds in this group were being treated with HN2. During 
this time, circulating leukocyte numbers fell below 3,000 
cell s/cu . mm . Following challenge with Heterakis eggs, there 
was a marked leukocytosis which persisted until the trial 
was terminated (Figure 2). This group had an average cell 
count of over 72,000 cells/cu . mm . when the trial was ter-
minated, 57 days after infection. 
Differential leukocyte counts 
Results of d.ifferential leukocyte counts are summarized 
in Tables 3 t hrough 7. Total heterophil and lymphocyte counts 
were markedly elevated 12 to 14 days postinfectio~. This was 
followed by a gradual fal l in numbers of both cell types to 
normal counts after treatment with dimetridazole . Transient 
increases in absolute numbers of heterophils were detected 
in Group 1 on days 44 and 57 postinfection but t here was no 
corresponding increase in the total number of l ymphocytes . 
Significant and persistent increases of heterophils and 
lymphocytes were observed in Group 2 starting with day 47 
postinfection (12 days postchallenge). 
Group 3 had a progressive decrease in absolute hetero-
phil and lymphocyte numbers while on treatment with HN2 . The 
decrease was more marked in heterophil counts than in the 
lymphocyte count s (Figures 3, 4, 5. 6) . After withdrawal of 
HN2, counts of both cell types began to increase rapidly, 
part i cularly the heterophi l counts which averaged well over 
29 
Table 3. Compari s on of the average total heterophil count s 
of three groups of turkeys during the experiment al 
eriod 
Days Post- Group Numbers 
infection 1 2 3 
7 (63.80)a (69.60) (58.80) 
12 , 300 b 19,300 15, 150 
12 (49 . 20) (57.00) (57.20) 
28, 500 27,800 31 , 600 
15 (45.40) (62.40) (62.00) 
15,350 28,800 26,550 
19 (56.RO) (61.40) (57 . 80) 
13,260 16,350 10,950 
22 (53.40) (54.40) (58 . 80) 
10,450 17,800 15,950 
26 (54.80) (51.20) (59.40) 
10,650 9, 150 13,900 
30 (56.00) (57. 80 ) (64.40) 
8,600 9, 800 7 . 950 
33 (56.25) (54.20) (64 . 00) 
13 , 800 10,950 7, 150 
35 (53.00) (44.60) (63.20) 
12 , 250 6,750 3,150 
40 (51 . 25) (53.00) (44 . 75) 
14,900 9.550 1,200 
44 (63 . 25) (56 . 00) (45 . 00) 
25,350 lJ,950 350 
47 (55.33) (64 . 75) (11.00) 
15,000 16,500 100 
50 (48.67) (55.50) (39.00) 
12,250 23,750 5.450 
54 (61.00) (65.75) (79.50) 
14,200 2R,950 43,350 
57 (65.67) (61.50 ) (70.00) 
23,500 32,700 48,400 
aReported as percentage . 
'hBeported as total numbers of cells/cu. mm. 
Figure 3. Absolute numbers of heterophils in the following groups in Trial I: 
Group 1 - Immune-control. 
Group 2 - Immune-challenged . 
Group 3 - RN2-treated. 
Infection at 7 days of age 
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Figure 4. Relative numbers of heterophils (expressed in per cent) for the 
following groups 1n Trial I: 
Group 1 - Immune- control. 
Group 2 - Immune-challenged. 
Group 3 - HN2-treated. 
Infection at 7 days of age 
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Table 4. Comparison of the average total eos1noph11 counts 
of three groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
infection 1 2 3 
7 (0.2o)a (0.00) (0.20) 
43 b 0 33 
12 ( 0.00) (0.00) (0.40) 
0 0 164 
15 (0.00) (0.40) (0.00) 
0 166 0 
19 (0.00) (0.40) (0.20) 
Q 102 37 
22 (0.80) (0.00) (0.20) 
143 0 99 
26 (0.20) (0.40) (0.00) 
25 75 0 
30 (0.40) ( 0.80) (0 .20) 
61 163 29 
33 (0.00) (0.20) (0.60) 
0 39 52 
35 (0.00) (0.60) (0 . 80) 
0 95 40 
40 (0.25) (0.00) (l.25) 
50 0 35 
44 (0.50) (0.75) (0.00) 
271 179 0 
47 (1.00) (1.25) (0.00) 
261 278 0 
50 (1.00 ) (0.75) (0.00) 
296 441 0 
54 (0.67) (0.25) (0.50) 
193 115 298 
57 (0.00) (1.00) (2.00) 
0 701 1,688 
aReported as percentage. 
~eported as total numbers of cells/cu. mm. 
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Table 5. Co~parison of the average total monocyte counts of 
three groups of turkeys during the experimental 
eriod 
Days Post- Group Numbers 
infection 1 2 3 
7 (o.oo)a (0. 80) (0. 80 ) 
0 b 164 179 
12 (0 . 2 0 ) ( 0 .00) (0 . 00 ) 
100 0 0 
15 (0 . 60) (0. 00) (0.20) 
169 0 41 
19 (0 . 00) (0 . 4 0) (0.20) 
0 86 37 
22 (0 . 2 0) (0. 80 ) (0 . 4 0) 
50 2 73 126 
26 (0 . 4 0 ) (0.60) (0 . 20) 
50 126 59 
JO ( 0 . 60) (0.2 0) (0 . 60) 
105 23 65 
33 (2 . 25) (1 . 20) (1 . 00) 
569 218 93 
35 (1 . 00) (2. 80) (3 . 00) 
179 292 157 
40 (1 . 75) ( 0 . 50) (2. 00 ) 
4 01 67 53 
44 (1 . 00) (2.00) ( 1 . 00) 
402 718 6 
4 7 (3 . 00) (1.50) (7. 00 ) 
1,270 462 56 
50 (1.33) (1.25) (1 . 50) 
265 443 150 
54 (0 . 67) ( 1. 00) (0 . 00) 
193 835 0 
57 (0 . 67) (1.25) (2 . 50 ) 
270 994 1. 928 
aReported as percentage. 
bReported as total numbers of cells/cu. mm . 
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Table 6. Comparison of the average total lymphocyte counts 
of three groups of turkeys during the experimental 
per i od 
Days Post-
1 nf ec t 1 on 
7 
12 
15 
19 
22 
26 
30 
33 
35 
40 
44 
47 
50 
54 
57 
1 
(31.40)& 
6,300 b 
(45.40) 
23. 350 
(48 . 60) 
15,350 
(36. 80) 
7.950 
(41.00) 
7,750 
(37. 60) 
7,300 
(37.40) 
6,000 
(37. 00 ) 
9,300 
(43 . 25 ) 
9.900 
(41.75 ) 
10 .150 
( 30.50) 
11,300 
( 37. 00 ) 
9 ,350 
(44. 33 ) 
11,200 
(32.67 ) 
7,650 
(29.67 ) 
9, 000 
&Reported as percentage. 
Group Numbers 
2 
(27. 00) 
6 , 850 
(37. 60 ) 
17, 800 
(J2.2 0 ) 
15.250 
(34. 00) 
9 , 150 
(37. 60 ) 
12, 300 
(40 .40 ) 
7, 300 
(34. 60) 
6,100 
(35.40) 
7' 100 
(44 . 80) 
6 , 250 
(41.75) 
7.500 
(37.50 ) 
9 . 950 
(28 . 00) 
6 ,1 50 
(38 . 00) 
15 ,000 
(29 .75 ) 
13,JOO 
( J2 . 25 ) 
15 .500 
~eported as total numbers of ce lls/cu. mm . 
3 
(J6. 80 ) 
8 ,900 
(J9.80) 
22,500 
(J4. 80) 
13,150 
(38 .40 ) 
7.350 
(35 . 80) 
8 , 000 
(35.60 ) 
8 ' 150 
(29.40 ) 
3,400 
(28 .40) 
2 , 600 
(27.60 ) 
1 , 350 
(45 . 25) 
1,150 
(51. 00 ) 
400 
(76 . 00 ) 
650 
(58 . 00 ) 
7,300 
(20 .50) 
11,500 
(24. 00) 
18 , 800 
Figure 5. Absolute numbers of lymphocytes i n the following groups i n Tr1al I : 
Group 1 - Immune-control. 
Group 2 - Immune-challenged . 
Group 3 - HN2- t reated . 
Infection at 7 days of age 
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Figure 6. Relative numbers of lymphocytes (expressed 1n per cent) for the 
following groups 1n Trial I: 
Group 1 - Immune-control . 
Group 2 - Immune-challenged . 
Group 3 - HN2-t reated. 
Infection at 7 days of age 
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Table 7. Comparison of the average total basoph11 counts of 
three groups of turkeys during the experimental 
period 
Days Post-
infection 1 2 3 
7 (4.6o)a (2.20) (3.40) 
944 b 571 761 
12 (5.20) (5.40) (2.60) 
2.573 2,635 1,220 
15 (5.40) (5.00) (2. 80) 
1,885 2.355 961 
19 (6.40) (3.80) (3.40) 
1,505 988 635 
22 (4.60) (7.20) (4.60) 
876 2,370 1,056 
26 (7.00) (7.2 0 ) (4.80) 
1,386 1,188 1,114 
JO (5.60) (6.60) (5.40) 
843 1,221 645 
33 (4.50) (9.00) (6.00) 
982 1,614 584 
35 (2.75) (7.20 ) (5.20) 
555 1,149 281 
40 (5.00) (4.75) (6.75) 
1,349 732 180 
44 (4.75) (J.75) (J.00) 
1,329 822 22 
47 (3.67) (4.50 ) (6.00) 
1,005 1,053 45 
50 (4.67) (4.50) ( 1. 50) 
1,291 1.782 181 
54 (5.00 ) (3 .2 5) (0.00) 
787 732 0 
57 (4.00) (4.00) (1.50) 
1,051 716 1,448 
aReported as percentage . 
bReported as total numbers of cells/cu. mm. 
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4R,OOO cells/cu. mm . at the time the trial was terminated. 
Eosinophils were infrequently seen and when present, 
they accounted for less than 2 per cent of the cells counted. 
I 
No signi ficant changes were observed in either the monocyte 
or basophil counts among all groups. 
SGOT Va lues 
Data for SGOT values for the 3 groups are g iven i n Table 
8 . Levels for serum glutamic-oxalacetate (SGOT) activity 
did not vary markedly from group to group . Ins te&d, greater 
variations wer e observed among individual birds t r.an between 
groups . 
Serum Protein Studies 
Results f or total serum protei n and serum protein 
fractions are summarized. in Tables 9 through 14. After 
challenge with Heterakis eggs, slightly higher tot al serum 
protein level s were observed in Group 2 t han in Group 3 
(Fi gure 7). Signi fi cant variations were observed in the 
serum albumin and gamma globulin fractions . A reduct i on of 
as much as JO to 50 per cent i n serum albumin levels was de -
tected in all groups 12 days postinfection (Figures 8 and 9). 
This was f ollowed by a rapid rise to "normal levels" after all 
birds were treated with dimetridazole . 
After challenge with He terakis eggs, albumin levels in 
43 
Table 8 . Comparison of serum glutamic- oxalacetic transaminase 
(SGOT) activity in three groups of turkeys dur ing 
the experimental period 
Days Post -
infection 1 2 2 
7 379.2oa (5)b 355.50 (4) 278.40 (5) 
12 279 . 60 (5) 318.00 ( 5) 278.40 (5) 
15 JlJ . 20 (5) 333.20 ( 5) 376.40 (5) 
19 320. 80 ( 5) 300 . 80 ( 5) 336.40 (5) 
22 319. 20 ( 5) 274 . 80 (5) 308 .40 (5) 
26 288 .00 (5) 278 .50 (4) 279 . 60 (5) 
30 284.80 ( 5) 312.00 ( 5) 285.60 (5) 
33 198.00 ( 1) 268. 80 ( 5) 336. 00 (4) 
35 358 .50 (4) 259 . 50 (4) 240.00 ( 2) 
40 237 . 00 (4) 262.50 ( 4) 318 . 00 ( 4) 
44 201 . 00 ( 4) 249.00 (4) 216 . 00 (2) 
47 238 . 00 (3) 184.50 ( 4) 327. 00 ( 2) 
50 238.00 (3) 186 .00 ( 4) 168. 00 (2) 
54 262.00 ( 3) 333.00 ( 4) 300 . 00 (2) 
57 224 . oo (3) 178.00 (J) J42.00 (2) 
asGOT r eported in S1gma- Prankel Units . 
bTot al number of birds used . 
Tabl e 9 . Compar i son of total serum protein value s of three 
gr oups of t urkeys during the experimental period 
Da ys Post- Group Numbers 
infection 1 2 2 
7 2 . 82a (5)b 2 . 60 ( 5 ) 2 . 60 (5) 
12 2 . 82 ( 5) J . 34 (5) 2.94 (5) 
15 3 . 02 ( 5) 3.58 ( 5) 3.38 ( 5) 
19 3.38 (5) 3.78 (5) 3.50 ( 5) 
22 3 . 50 (5) 3. 84 ( 5) 3.38 (5) 
26 J . 52 ( 5) 3. 72 ( 5) J.36 (5) 
30 J.80 ( 5) 4 . 00 ( 5) J . 30 (5) 
33 3. 82 (4) 4.12 ( 5 ) J.56 ( 5) 
35 4 . 05 ( 4) 4.68 (5) J.28 (5) 
40 4 . 55 ( 4) 3.63 ( 4) 2 . 72 (4) 
44 4. 07 (4) 3.77 ( 4) 3.25 ( 2) 
47 5.03 (3) 4.15 (4 ) J.45 (2) 
50 4.90 ( J) 4.10 ( 4) 2 .95 (2) 
54 J.77 (3) 4 . 07 ( 4) 3.40 (2) 
57 4.07 ( J) 3.75 ( 4) J . 30 (2) 
aReported as gr ams/100 ml. of serum. 
bTotal number of birds used. 
Figure 7. Progressive changes in total serum protein in the following groups 1n 
Trial I: 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group 3 - HN2-treated. 
Infection at 7 days of age 
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Table 10. Comparison of total serum albumin concentration in 
three groups of turkeys during the experimental 
period 
Days Post-
infection 1 
Group Numbers 
~ 2 
7 1.14 a (5)b 0 .98 ( 5) 0 . 94 (5) 
(40.JO)C {J?.42) (J6.13) 
12 0 .74 ( 5) 0 . 65 ( 5) 0 . 65 (5) 
(25.38) (19.39) (21.83) 
15 0 .78 ( 5) 0 .92 (5) 0. 95 ( 5) 
(26.03) (25.64) (27.75) 
19 1.19 ( 5) 1.JO (5) 1.17 (5) 
(35.66) (34.63) ( 33. 72) 
22 1.30 (5) 1.46 (5) 1.Jl ( 5) 
(37.15) (38 .43) (39 . 57) 
26 1.42 (5) 1.37 (5) 1.27 (5) 
(40.63) (36.93) (37. 87) 
JO 1.39 (5) 1.58 ( 5) 1.26 (5) 
(36.65) (39.57) (37. 87) 
33 1.54 ( 4) 1.62 (5) 1.21 (5) 
(40.38) (39.32) (JJ.20) 
35 1.34 ( 4) 1 .58 ( 5) 1. 02 (5) 
(31.75) (3J.91) (J0 . 07) 
40 1.12 (4) 1.34 (4) 0 . 87 ( 4) 
(26.64) (37.21) (27.79) 
44 1.56 (4) 1.48 ( 4) 1.26 (2) 
(36.0l) (39.96) (38.64) 
47 1.47 ( J) 1.J4 ( 4) 1 .41 (2) 
( 32. 82) (J4.1 B) (41. 08) 
50 1.65 (J) 1.15 ( 4) 0.87 (2) 
(35.02) (27 .19) (29.45) 
54 1.25 ( 3) 0 . 93 ( 4) 0 .45 ( 2) 
( 32. 52) (22.68) (lJ.Jl) 
57 1.16 ( J ) 0 .77 ( 4) 0.21 (2) 
( 31. 42) (20 . 78) (6.24) 
aReported as grams percent. 
bTotal number of birds used. 
CReported as relative percent. 
Figure 8. Progressive changes in serum albumin concentration (expressed in grams 
per cent) for the following groups in Trial I: 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group J - HN2-treated. 
Infection at 7 days of age 
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Figure 9. Progressive changes i n serum albumin concentration (expressed as per 
cent of the total serum protein) i n the following groups in Trial I: 
Group 1 - Immune-control . 
Group 2 - Immune-challenged . 
Group 3 - HN2-treated . 
Infection at 7 days of age 
DIMETRIDAZOLE 
40 
I 
I 
I 
~ 
35 I I z: ,__. I I 
z: 
I I I C> 30 ,__. .._ 
I I ~ I I .._ I I z: I w 25 I u z: I C> I u I z: 20 I - I E: I :::::> 5 I \J\ I 0 c:r:: 15 
:E: TRIAL I . I I 
:::::> 
I a::: GROUP ONE I w 0 
(/) 10 I I • GROUP TWO w I L9 
GROUP THREE I ~ I w 5 > I I c:r:: 
I 
0 
14 19 20 24 29 34 36 39 44 49 54 59 64 69 
AGE OF BIRDS, IN DAYS 
51 
Table 11. Conpari son of total serum alpha 1 globulin concen-
tration in three groups during the experimental 
period 
Days Post-
1nfec t1on 
7 
12 
15 
19 
22 
26 
JO 
33 
35 
40 
44 
47 
50 
54 
57 
1 
0 . 26 a 
(9.32)b 
0.22 
( 7.77 ) 
0 . 31 
( 1 0 . 45) 
0 . 3R 
(11 .39) 
0 . 39 
(11 .1 3) 
0 . 35 
(9 .90) 
o . 43 
(11 . 30) 
0 . 39 
(10.29) 
o . 46 
(11 . 69) 
0 . 48 
(11 . 14) 
0 . 46 
(11 .1 0) 
o . 4o 
(9 . 50) 
0 . 36 
(7 . 97 ) 
0 .32 
(8 . 79) 
o. 32 
(R. 17) 
Gr oup Numbers 
2 
0.24 
(9 . 11) 
0 . 34 
(9.94 ) 
0. 39 
(1 0 . 87 ) 
0 .36 
(9.48 ) 
0 . 37 
(9 . 62) 
o.41 
(10.99) 
0 . 46 
(11.44) 
0 .36 
(8 . 84) 
o .49 
(10 . 62) 
o . 41 
(11.45) 
0 .38 
(1 0 . 30) 
0 . 41 
(1 0 .57) 
0 . 42 
(10.73) 
o . 41 
(1 0 . 24) 
0 . 29 
(R .58) 
aReported as grams percent. 
b Reported as relative percent. 
3 
0 .21 
(8 . 20) 
0 . 32 
(11 . 01) 
0 .31 
(9.14) 
0.37 
(1 0 .73) 
0 . 35 
(1 0 . 55) 
0 . 35 
(10 . 62) 
0 . 37 
( 11.42) 
0 .41 
(11.74) 
0 . 31 
(9 . 79) 
0 .40 
(15 . 56) 
o. 32 
(9. 8 1) 
0 . 32 
(9.11) 
0 . 37 
( 12 .56 ) 
o .43 
(12 . 86 ) 
0 . 2 8 
(A .39) 
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Table 12. Comparison of total serum alpha II globulin concen-
tration in three groups of turkeys during the ex-
perimental period 
Days Post- Group Numbers 
infection _j__ 2 
7 o.45 a o . 46 o . 47 
(16.oo)b (18 . 07) (18 . 47 ) 
12 0 . 63 0 .72 0 . 63 
(2 3 .33) (21 . 59) (21. J O) 
15 0 . 51 0.57 0 . 56 
( 16 . 71) (15.85) (16.42) 
19 0 . 44 0 . 52 o .46 
(12 . 97) (1J . 66) (13 . 11) 
22 o.49 0 . 52 o . 49 
(14 . 09) (lJ . 54) (14 .JJ ) 
26 0 . 51 0 .51 o . 48 
(14 . 57) (lJ . 59) (14 . 25) 
JO 0 . 61 0 .51 0 . 47 
(15 . 93) (12. 81) (14 . 74) 
33 0 . 62 0.57 o . 64 
(16.1 8) (lJ . 92) (18 . 28 ) 
35 0 . 77 0 . 86 0 . 74 
(20 . 25) (18 . 07) (22 . 94) 
40 0 . 67 0 . 51 0. 55 
(1 4. 92) (14.05) (22 . 85 ) 
44 o.66 0 . 61 0. 55 
(16 . 57) (15 .75 ) (16 . 87) 
47 0 . 65 o . 64 0 . 53 
(12 . 70) (15 . 11) (15 . JO) 
50 0 . 72 0 .78 0. 59 
(15 . 11) (20.23) (20 . 2)) 
54 0 . 71 0.72 0 . 91 
(19 . 24) (1 8 . 19) (26 . 88 ) 
57 0 . 71 0 . 54 o . 64 
(16 . 75) (15 . 45) (19 . 27) 
aReported a s grams percent. 
bRepor ted as rela tive percent . 
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Table 13. Comparison of total seru~ be ta globulin concen-
tration of three groups of turkeys during the ex-
per imental period 
Days Post-
infecti on 
7 
12 
15 
19 
22 
26 
30 
33 
35 
40 
44 
47 
50 
54 
57 
1 
0. 75 a 
(26.48)b 
0.83 
(29.63) 
0 . 74 
(24.38) 
0 . 73 
(21.65) 
0 . 75 
(21 . 34) 
0 . 74 
(20 . 95) 
0 . 91 
(2J. 93) 
0 . 8J 
(21 . 65) 
0 . 99 
(24 . 67) 
0 . 96 
(21 . 56) 
0 .81 
(20 . 0J) 
1 . 08 
(22 . 0J) 
0 . 93 
(21 . 16) 
0 . 80 
(21.27) 
1 . 06 
(24. 95) 
Group Numbers 
2 
o . 64 
(24.45) 
0 . 98 
(29 . JO) 
0 . 78 
( 21. 91 ) 
0 .74 
(19. 50) 
0 . 76 
(19.83) 
O. R6 
(23. 00) 
0 .92 
(22.99) 
1 . 06 
(25.67) 
1 . 15 
(24 . 77) 
0 . 88 
(24 . 06) 
0 . 79 
(2 0 . 91) 
1 . 02 
(23 . 84) 
0 . 93 
{23 . 36) 
0 . 8R 
(21.99) 
0 . 72 
(19. 43) 
aReported as gra:ns percent. 
~eported as relative percent . 
3 
0. 71 
(27 . 21) 
0 .78 
(26.76) 
0 . 76 
(22 . 36) 
0. 77 
(22 . 14) 
0 . 65 
(19 . 17) 
0 .73 
(21.68) 
0 .76 
(23 . 33) 
0 . 91 
(25 . 91) 
0 . 89 
( 2 7 . 54) 
0 . 62 
(2J . 76) 
o . 69 
(21.16) 
0 . 87 
(25 . 12) 
0 . 76 
(25.51) 
0 . 85 
( 2 5. 02) 
0 . 84 
(25 . 56) 
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'l'able 14 . Comparison of total seru~ gamma globulin concen-
tration of three groups of turkeys during the ex-
perimental period 
Days Post- Group Nu'!lbers 
infection 1 2 
7 0 . 22 a 0 . 29 0 . 27 
(7 . 9o)b (10.95) (9.99) 
12 o.41 0 . 65 0 .55 
(13 . 90) (19.79 ) (19 .11 ) 
15 0 . 69 0 . 91 0.81 
(22.42) (25.73) (24.32) 
19 0.63 0 . 86 0.73 
(18 . 34) (22 .72) (20.30) 
22 0 . 5R 0 . 72 0.57 
(16 . 30) ( lR . 58) (16.37) 
26 0 . 50 0 . 58 0 . 53 
(13.94) (15.49) (15 . 57) 
JO 0 .47 0 .53 o.43 
(12.19) (13 .19) (12 . 65) 
33 0 . 44 0 . 51 0.39 
(11 . 50) (12 . 25) (10 . 86) 
35 o . 48 0 . 60 0 . 32 
(11 . 64) (12 . 64) (9. 65) 
40 1 . 32 o .48 0 . 28 
(25 . 75) (13 . 22) (10.04) 
44 0.60 0 . 51 o .44 
(16 . )0) (lJ . 08) (13 . 52) 
47 1.43 0 .74 0 . 33 
(22 . 94) (16 . 29) (9.39) 
50 1 . 21 0 . 83 0 . 36 
(2 0 . 75) (1 8 . 49) (12 . 25) 
54 0 . 69 1 . 14 0.75 
(18 . 17 ) (26 . 90) ( 21 . 92) 
57 0 . 81 1.43 1 . J4 
(18. 71 ) (35.76) (40 . 54) 
a.Reported as grams percent . 
bReported as relative percent . 
Figure 10 . Progressive changes i n serum gamma globulin concentration (expressed 
in grams per cent) for the following groups in Trial I : 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group 3 - HNz-treated. 
Infection at 7 days of age 
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Figure 11. Progressive changes in serum gamma globulin concentration (expressed 
as per cent of total serum protein) i n the following groups in 
Trial I : 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group 3 - HN2-treated. 
Infection at 7 days of age 
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Groups 2 and 3 g radually fe ll below normal levels and re -
mained within this range for t he remainder of the experimen-
tal period . The fall was most remarkable in Group 3 where 
the albumin levels dropped to 0 . 21 gm . per cent t he day the 
experiment was terminated. . In contrast, a twofold increase 
in gamma g lobulin levels was detected in all 3 gro ups 12 days 
postinfection (F i gure s 1 0 and 11). The level dropped to 
within the normal tange after treatment with dime tridaz ole . 
Transient increases in gamma globulin levels were detec ted in 
Group 1 on da ys 40 and. 47 postinfection ( two birds in this 
group had ver y hig h gamma globulin levels on these days). 
Following cha llenge with Heterakis e bgs , marked i ncreas e s in 
gamma g lobulin levels were detected in both Groups 2 and J. 
There we~e no significant changes in either alpha or beta 
g lobulin fractions among all the 3 groups . 
Histopatholog ic Studies 
Grou p l - i rn~une- control birds 
Of the 2 birds which died before the trial was terminat -
ed, g ross lesions were observed in the li ver and ceca of one 
while lesions in the other bird were c onf ined to the ceca . 
The re~alni ng 3 birds which were killed and necropsied at the 
end of the trial period did not have any significant lesions. 
Liver lesions The histopatholog ic alterations of the 
g ross lesions consisted of focal necro t ic areas diffusely 
60 
scattered throughout the liver parenchyma . Multinucleated. 
g iant cells were numerous within these necrotic areas and 
many contained degenerati ng hi stomonads. There was an in-
tense mononuclear cell infiltrati on in the surrounding tissue . 
Histomonads were frequently observed in d isrupted hepatic 
sinusoids and bile duct proliferation was quite marked. Dis-
crete areas of resolving lesions were present in liver 
sections from one other bird. 
Liver sections from birds whi c h had no gross lesions did 
not contain h istomonads (F igures 12 and 13). Wel: circum-
scribed lymph oid cell accumulations, the so-called "bursa-
dependent f ol licles", wer e fr equently found scatter ed through-
out the parenchyma and tended to be more numerous near blood 
vessels. 
Cecal lesi ons The cecal lumina of birds which had 
g ross lesions were filled with ne crot i c masses consisting of 
cellular debris, fibrin, and bacterial colonies. The mucosal 
lining was ulcerated and a granulomatous inflammation in-
v olved all l a yers of the cecal wall. There was an intense 
mononuclear cell infiltration int o the lamina propria, sub-
mucosa, and serosa . Giant cells were numerous in both the 
mucosa and submucosa. Serosa l vessels were congested and the 
mesentery was infiltrated by large numbers of mononuclear 
cells and a few polymorphonuclear leukocytes. Secti on s fr om 
ceca whi ch did not have g ross lesi ons were characterized by 
an intense lymphocytic cell infiltrate i n mucosa and sub-
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mucosa (Figures 14 and 15 ) . Lymphoid foci, similar to those 
found in the liver, were frequently found in lamina propria 
and occasionally in other layers. No histomonads were ob-
served. 
Lesions in other tissues Well-circumscribed lymphoid 
foci were frequently observed in the spleen (Figures 16 and 
17), small intestine, and bronchial mucosa. Definitive micro-
scopic lesions were not observed in the kidney, myocardium., 
or the bursa of Fabricius (Figures 18 and 19). 
Group 2 - immune-challenged birds 
One bird which died before this g roup was challenged 
w1 th virulent histomonada d.1d not have gross or mi croscopic 
lesions. All the remaining birds were killed 25 days post-
challenge. Two birds had cecal lesions but no gross lesions 
we r e observed in either the liver or any other tissues. 
Liver lesions Focal areas of lymphoid cell accumu-
lation surrounded by scanty, fibrous stroma were observed 
near hepatic vessels (Figures 20 and 21 ) . A focal resolving 
lesion was observed in one section. 
Cecal lesions The microscopic lesions in birds which 
did not have gross lesions consisted of an intense lympho-
cytic infiltration into all l ayers of the cecal wall. The 
~eaction was most marked in the mucosa and submucosa. Well 
circumscribed lymphoid foci ( similar to those seen in the 
liver) were present in lamina propria and submucosa (Figures 
Figure 12 . Liver section from an immune control bird. 
Hematoxylin and eosin stain. X 64 
Figure lJ . Higher magnification of a portion of F igure 12. 
Hematoxylin and eoain stain. X 400 

Figure 14. Section of cecum from an immune control bird. 
Hematoxylin and eosin stain . X 64 
Figure 15. Higher magnification of a portion of Figure 14. 
Hematoxylin and eosin stain . X 400 

Figure 16. Section of spleen from an immune control bird .. 
Hematoxylin and eosin stain. X 64 
Figure 17. Higher magnif ication of a portion of Figure 16 . 
Hematoxylin and eosin stain. X 400 

Figure 18. Typical section of the bursa of Fabricius from 
immune control birds. Hematoxylin and eosin 
stain. X 64 
Figure 19. Higher magnification of a portion of Figure 18. 
Hematoxylin and eosin stain. X 400 

Figure 20. Lymphoid follicles in liver section from an 
immune-challenged bird. Hematoxylin and eosin 
stain. X 64 
Figure 21. Higher magnification of the lymphoid f ollicle in 
Figure 20. Hematoxylin and eosin stain. X 400 

Figure 22. 
Figure 23. 
Numerous lymphoid follicles and extensive mono-
nuclear oell infiltration in cecal wall of an 
immune-challenged bird. Hematoxylin and eosin 
stain. X 64 
Higher magnification of one of the follicles in 
Figure 22 . Hematoxylin and eos1n stain. X 400 
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22 and 2J ) . In one bird, the cellular response consisted of 
polymorphonucl ear leukocytes, principally heterophils. 
The hi~topathologic alterations in the ceca which had 
g r oss lesions were a granulomatous tissue reaction involving 
all layers of the cecal wall and extending into the adjacent 
mesentery. Histomonads were found free in lamina propria or 
su~ rounded by numexous multinucleated giant cells. The 
mucosal lining was ulcerated and the cecal lumen contained 
necrotic cellular debris, epithelial cells, and c olonies of 
bacter ia. 
Les i ons in other tis sues Lymphoid follic l es (bursa-
dependent follicles) were frequently observed in t he spleen 
(Figures 24 and 25) and small intestine and were occasionally 
seen in bronchial mucosa. The bursa of Fabricius was en-
larged and its follicles were prominent. A thin connective 
tissue stroma separated individual follicles (Figures 26 and 
27) . 
No significant microscopic changes were observed in the 
myocardium, large intestine, or the lungs. 
Group l - HN2-treated bir d s 
Three birds died between 6 and 9 days after challenge 
and the remaining 2 b i rds were killed and necropsied 25 days 
after challenge (the day the trial was terminated). Gross 
l esions were observed in the livers and ceca of all birds. 
Small granulomas were occasionally observed i n t he lungs, 
Figure 24. 
Figure 25. 
Spleen section from an immune-challenged bird. 
Hematoxylin and eosin stain. X 64 
Higher magnification of a portion of Figure 24. 
Hematoxylin and eosin stain. X 400 

Figure 26 . 
Figure 27. 
Section through the bursa of Fabricius f rom an 
immune-challenged bird. Bursal fol licles are 
filled with round, dark staining cells. 
Hematoxylin and eosin stain. X 64 
Higher magnification of a portion of Figure 26 . 
Hematoxylin and eosin stain. X 400 
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kidneys and the bursa of Fabricius of some of these birds. 
Liver lesions Microscopic liver lesions consisted 
of large areas of coagulative necrosis with poorly defined 
borders . Giant cells were numerous in these necrotic areas 
and often contained degenerated histomonads. Individual or 
"nested" histomonads were present at the peripheries of these 
necrotic areas, around blood vessels and in hepatic sinusoids 
(Figures 28 and 29). The associated cellular response was 
quite mild and consisted of mononuclear and epithelioid cells. 
Macrophages filled with pigment were f requently f ound in 
these sections. 
Cecal lesions Mi croscopic les ions consis t ed of 
massive invasion of all layers of cecal wall by hi stomonads 
(Figures JO and 31). The mucosa was ulcerated and small 
necrotic foci were frequently observed in the submucosa. 
Large numbers of giant cells and macrophages were present in 
the lamina propria. No bursa-dependent follicles were ob-
se r ved in any sections . 
Lesions in other tissues 
Spleen There was an apparent loss of basophil-
i c staining cells of the white pulp and a concurrent increase 
in the number of reticular cells (Figures J2 and JJ). Bursa-
dependent follicles and histomonads were not observed in these 
sections. 
Kidney Focal granulomas consisting of histomonads 
surrounded by mononuclear cells were found in kidney sections 
Figure 28 . Numerous histomonads and giant cells in the ~iver 
section typical of HN2- treated group. Hema-
toxylin and eosin stain. X 64 
Figure 29. Higher magnification of a portion of Figure 28. 
Hematoxylin and eosin stain. X 400 

Figure JO. Ulcerated mucosal lining of cecum from HN2-
treated group. Numerous histomonads are present 
in cecal wall. Hematoxylin and eosin stain. 
x 64 
Figure Jl. Higher magnification of a portion of Figure JO. 
Hematoxylin and eos1n stain. X 400 

Figure 32. Typical section of spleen from HN2-treated group. 
There is depletion of lymphoid cells. Hema-
toxylin and eosin stain. X 64 
Figure 33. Higher magnification of a portion of Figure 32. 
Hematoxylin and eosin stain. X 400 
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from 2 birds. Microscopic changes from other kidney sections 
were not remarkable. 
Lung Histomonads were not observed in any of the 
lung sections. However, 2 birds with lung lesions had a 
chronic granulomatous pneumonia. A mycotic agent, probably 
Aspergillus ~· was observed in air sacs and in many of the 
blood vessels. 
Bursa of Fabric1us This structure was generally 
smaller in this group than in Groups 1 and 2. Follicles 
appeared smaller and contained far fewer cells than equivalent-
sized follic l es of immune-control birds (Figures 34 and 35). 
There was a marked increase in interfollicular connective 
tissue. Giant oells were occasionally observed in some 
follicles. Histomonads were present i n sections of this 
structur e from 2 different birds (Figures J6 and 37). 
Myocardium, duodenum, small intestine, and pancreas 
The histopathologic alterations observed in these tissues 
were not remarkable. 
Trial I I 
Mortality 
Mortality in Groups 1, 2, and J we r e 0/4, 0/4, and J/ 5, 
r espectively. 
Body Weights 
Data on body weights for the J gr oups a re gi ven in Table 
Figure 34. 
Figure 35. 
Section of the bursa of Fabricius from a HN2 -
treated bird. There i s atrophy of the bur sal 
follicles and depletion of follicular cells. 
Hematoxylin and eosin stain. X 64 
Higher magnification of a por tion of Figure 34 . 
Hematoxylin and eosin stain. X 400 
co
 
co
 
FiguTe 36. 
Figure 37 . 
Protozoal granuloma in the bursa of Fabricius 
from a HNz - treated bird. Single and clusters 
of histomonads are present. Periodi c acid-
Schiff (PAS) stain. X 64 
Higher magnification of the granuloma in Figure 
36. Periodic acid- Schiff (PAS) stain. X 400 
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15. There were no sign i ficant d ifferences between Groups 1 
and 2 with regard to weight gains (Figure 38). Birds in 
Group 3 gained comparatively less weight than birds in Groups 
1 and 2. 
Hematologic Observati ons 
Detailed results of hematologic observations for all 
groups a r e summarized in Tables 16 through 21. The responses 
were similar ln kind and magnitude to those descr ibed for 
Trial I (Figures 39 through 43) except that, in t hi s trial, 
t he total lymphocyte numbers first rose then steadily dropped 
t o norma l values (Fi gures 42 and 43 ) . 
SGOT Stud i es 
Data for SGOT values are given in Table 22 . Marked var-
iat ions i n SGOT values were observed a mong individual birds 
and between groups . These changes were simila r t o those 
obser ved in Trial I . 
Serum Protein Studies 
Res ul ts of s erum pr otein dete1minat1ons were essentiall y 
si milar t o those obtained in Trial I and are summarized in 
Tables 23 through 28 . Following challenge, total serum 
pr.ot ein concentrat ion was slightly higher in Group 3 t han in 
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Table 15. Compar ison of average weights (in grams) of three 
groups of turkeys during the experimental period 
Days Post- Group Numbers 
infection 1 ~ 2 
6 83 (4)a 96 ( 4) 87 ( 5) 
13 116 ( 4) 121 ( 4) 120 (5) 
16 133 ( 4) 141 (4) 138 ( 5) 
23 185 (4) 197 ( 4) 188 ( 5) 
27 243 (4) 251 (4) 236 (5) 
30 271 ( 4) 291 (4) 266 (5) 
35 333 ( 4) 377 ( 4) 302 (5) 
37 334 ( 4) 396 ( 4) 276 (5) 
41 323 (4) 431 ( 4) 349 (5) 
44 393 ( 4) 502 ( 4) 398 (5) 
47 480 ( 4) 555 (4) 440 (5) 
50 577 ( 4) 625 ( 4) 440 (4) 
54 768 (4) 770 (4) 581 (3) 
57 8J1 (4) 773 ( 4) 660 ( 2) 
61 1, 021 (4) 874 (4) 802 (2) 
64 1,156 (4) 1,057 ( J) 859 (2) 
~otal number of birds used . 
Table 16 . Compar ison of average total leukocyte counts of 
three groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
infection 1 ~ J 
6 19,350 (4)a 22,JOO ( 4) 20,850 ( 5) 
13 26 , 850 (4) 44,050 ( 4) 34,500 ( 5) 
16 37.200 ( 4) 44,250 (4) )2,900 (5) 
23 19 . 500 (4) Jl,050 (4) 22,100 ( 5) 
27 17,050 ( 4) 20,800 ( 4) 20,500 (5) 
JO 18,150 (4) 23, 100 (4) 17,650 (5) 
35 19.100 {4) 17,400 ( 4) 23,950 (5) 
37 23,400 ( 4) 17,200 (4) 24,450 (5) 
41 33,600 ( 4) 19,450 ( 4) 31 , 450 ( 5) 
44 40,500 ( 4) 27 ,250 (4) 19, 050 (5) 
47 46,950 ( 4 ) 32,150 { 4) 11,400 ( 5) 
50 25,750 ( 4) 34,550 ( 4) 9 , 900 (4) 
54 18 , 450 (4) 44.150 ( 4) 9.250 (3) 
57 21,550 (4) )2, AOO ( 4) 14,250 ( 2) 
61 2),450 ( 4) 28 ,150 (4) 20,600 (2) 
64 22.200 ( 4 l 2P1 800 ( J l 11 1 ~ 00 (2~ 
B.irotal number of birds used. 
Figure JS. Progressive changes 1n the body weights of the following groups 1n 
Trial II: 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group J - HN2-treated. 
Infection at 7 days of age 
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F1gure 39. Total leukocyte response pattern of the following groups 1n Tr1al II : 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group J - HNz-treated . 
Infection at 7 days of age 
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Table 17. Comparison of the average total heter ophll counts 
of three groups of turkeys during the experimental 
period 
Days Post- Groups Numbers 
infecti on 1 2 J 
6 (44.75)~ (42.50) (40.60) 
8, 500 9.550 8,450 
13 (69.75) (66.00} ( 74.40) 
19, 150 28,850 25,900 
16 (56.50) (49 . 50) (52 . 00} 
22, 100 21,900 17'150 
23 (56.50) (65.75 ) (47.60) 
11,150 20 ,400 10, 800 
27 (37 -75) (39 -50) ()6 .40) 
6,500 8 , 150 7.450 
JO (47.00) (49.00) (45.20) 
8,600 11, 150 7.950 
35 (56.50) (57-75) (56.40) 
10,850 10,200 13 ,700 
37 (59 -75) (56 .75) (58 . 60) 
14,000 9,700 14,750 
41 (67.00) (66.50) (65 . 80) 
23 , 000 1),000 21,250 
44 (48 . 25) (54 .75) (71.00) 
19,050 14,750 13,600 
47 (54 .50) (5) . 00) (55.00) 
25,800 17,000 6,250 
50 (53-75) (59 -50) (50 .75) 
14,600 20,350 5 . 050 
54 (48 . 75) (54. 00) (44.67) 
9 '100 23,250 4 , 650 
57 (54.50) (59.50) (58.50) 
12,200 18 ,700 9 ,250 
61 (57-50) (49 .75 ) (61.00) 
lJ,850 14,250 12,950 
64 (55.50) (50 . 00) (65.00) 
12,850 14,700 7,.500 
8Reported as percentage. 
~eported as total numbers of cells/cu. mm . 
F1gure 40 . Absolute numbers of heteroph1ls in the following groups in Trial II: 
Group 1 - Immune-control. 
Group 2 - Immune - cha llenged. 
Group 3 HN2-t reated . 
Inf action at 7 days of age 
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Figure 41. Relative numbers of heterophils (expressed in per cent) for the 
following groups in Trial II : 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group J - HNz-treated. 
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Table 18. Comparison of the average total eos1noph11 counts 
of three groups of turkeys during the experimental 
period 
Days Post-
1nfection 
6 
13 
16 
23 
27 
30 
35 
37 
41 
44 
47 
50 
54 
57 
61 
64 
1 
(0.25)~ 
59 
(0.50) 
172 
(0.25) 
77 
(0.50) 
113 
(0.25) 
37 
( 1.25) 
232 
(0.50) 
125 
(0. 00 ) 
0 
(0.25) 
44 
(0.25) 
64 
(0.50) 
220 
(0.00) 
0 
(0.00) 
0 
(0.50) 
103 
(0.50) 
142 
(1.00) 
239 
aReported as percentage. 
Group Numbers 
2 
(0.50) 
1 04 
(1.00} 
566 
{0.25) 
125 
(0.50} 
111 
. (0.25) 
55 
(0.25} 
46 
(0.00} 
0 
( 0.00) 
0 
( 0 .00) 
0 
(0.00 ) 
0 
(1.25) 
528 
(0.50) 
207 
( 0 .75) 
383 
(0 . 75) 
270 
(0.50} 
12 0 
(0 • .33} 
78 
~eported as total numbers of cells/cu. mm. 
3 
(0.40) 
82 
(0.20) 
70 
(0.20} 
61 
(0.40) 
113 
(0.60) 
114 
(0.40 ) 
64 
(0.00) 
0 
(0.00) 
0 
( 0 .00) 
0 
(0.40) 
51 
(0.60) 
75 
(0.00) 
0 
(0 . 00) 
0 
(0.00) 
0 
(0.50) 
142 
(0.00) 
0 
103 
Table 19. Comparison of the average total monocyte counts of 
three groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
1nf ection 1 2 J 
6 (0.25)a (0. 00) (0.60) 
59 0 133 
13 (0.25) ( 0 . 00) (0.00) 
72 0 0 
16 (0.50) (0 .25) (1. 00 ) 
304 125 306 
23 (0.75) (0.25) (0.60) 
136 162 127 
27 (0.25) (0.75) (1.20) 
37 138 263 
JO (0.00) (0. 25) (1.40) 
0 53 231 
35 (0 . 50) ( 0 .50 ) (1.20) 
93 97 337 
37 (0.00) (0.00) (1.00) 
0 0 286 
41 (0.50) (0.50) (0.00) 
132 85 0 
44 (0.50) ( 0 . 00 ) (0.2 0 ) 
129 0 26 
47 (0.75) (0.50) {1.00 ) 
357 122 130 
50 (0.25) (1.50) (1.25) 
42 542 93 
54 (0.50 ) ( 0.50) (0. 67) 
62 222 42 
57 ( 0 . 50) ( 0 .50 ) (1. 00 ) 
87 185 79 
61 {0.50) (1 . 50) (1.00) 
105 423 206 
64 (0.50 ) ( 0 .67) (1.00 ) 
158 206 115 
aRe ported as percentage. 
~eported as total numbers of cells/cu . mm . 
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Table 20. Comparison of the average total lymphocyte counts 
of three groups of turkeys during the experimental 
per1od 
Days Post- Group Numbers 
1nfect1on 1 ~ 
6 (53.25)~ ( 52. 2 5) (54. 80 ) 
10,400 11, 600 11,450 
13 {27.50) (J0.25) (2J.2 0 ) 
6,850 13,250 7.750 
16 (40.25) (45.50) ( 42. 40) 
lJ,900 20, l 00 13.900 
23 (39.25) (30.75) (45. 80 ) 
7.500 9.550 9. 850 
27 (55.75) (52.50 ) (58 .20) 
9 . 350 11, 000 11,900 
30 (48.50) (45 .00) (46 . 80 ) 
8 ,700 10,600 R, 300 
35 (3A.75) (36.00) ()9. RO ) 
7 ,250 6,200 9.350 
37 (37.00) (38 .25) (37. 80 ) 
8 ,650 6,600 9 , 000 
41 (29.25) (29 . 00) (32.20) 
9,450 5,600 9,650 
44 {48 .50) (39.25) (2).80) 
20.250 11.250 4,500 
47 (40.00) (42.50 ) (37.60) 
18,550 13, 650 4,JOO 
50 (41.75) (34.75) (41.75) 
10,050 12,200 4,000 
54 {45.25) {41 . 50) (50 .00) 
8, 200 18,700 4, 000 
57 (39. 00) {34 .75) (33.50) 
8 ,100 12,000 4,000 
61 ()7.00) (41 . 00) (35. 00 ) 
8 ,250 11,300 6 ,750 
64 (JR.OO) (40 . 67 ) {29.00) 
9,600 11,350 J,JOO 
aReported as percentage. 
~eported as total numbers of cells/cu. mm. 
Figure 42. Absolute numbers of lymphocytes in the following groups in Trial I I: 
Group 1 - Immune-control . 
Group 2 - Immune-challenged. 
Group 3 - HN2-treated . 
I nfection at 7 days of age 
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Figure 4). Relative numbers of lymphocytes (expressed in per cent) for the 
following groups 1n Trial II : 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group 3 - HN2-treated. 
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Table 21. Comparison of the average total basophil counts of 
three groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
infection 1 2 2 
6 (3 . 00)a (4.75) (3.60) 
569 b 1,080 788 
13 (2.00) (2 . 75) (2.2 0 ) 
574 1,384 768 
16 (2.50) (4.50 ) (4 . 20 ) 
792 1,991 1,401 
23 (3 .00) (2.75) (5 . 60) 
611 858 1,245 
27 (6.00) (7.00 ) (3 . 60) 
1,105 1,476 772 
30 (3.25) (5.5 0) (6 .20 ) 
591 1, 230 1,075 
35 (3.75) (5.75) (2 . 60) 
765 926 536 
37 (3.25) (5.00) (2.60) 
748 885 376 
41 (3.00) (3.00) (2 . 00) 
1,008 555 533 
44 (2 .75 ) (6 . 00) (4 . 60) 
1,185 1,260 843 
47 (4 .25 ) (2.75) (6 .2 0) 
2,014 818 668 
50 (4.25) (3 .75 ) (5.75) 
1,068 1 ,2 09 745 
54 (5 .25) (3.25) (4.67) 
1,022 1,612 554 
57 (5.50) (4 . 50) (7 . 00) 
1,016 1,615 934 
61 (4.50) (7 . 25) (2.50) 
1,067 2,017 554 
64 (5.00) (8.00) (5 . 00 ) 
1, 020 2,339 574 
aReported as percentage. 
bReported as total numbers of cells / cu. mm. 
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Table 22. Compari s on of serum glutamic- oxalacetic trans-
aminase (SGOT) activity in three groups of turkeys 
dur ing the experimental period 
Days Pos t - Group Numbers 
infe ction 1 2 J 
6 272 .ooa (3)b 212 . 00 ( 3 ) 297 . 60 (5) 
13 217.00 ( 4) 218 . 00 ( 3) 307 . 50 ( 4) 
16 213 . 00 ( 4) 21 0 . 00 ( 4) 222.00 ( 4) 
23 208 . 50 ( 4) 213 . 00 ( 4) 208 . 80 ( 5) 
27 219 . 00 ( 4) 240.00 ( 4) 253 . 20 ( 5) 
JO 253. 50 ( 4) 236.00 ( 3) 254 . 40 (5) 
35 205 . 50 ( 4) 2.58.00 ( 4) 301.20 (5) 
37 187. 50 ( 4) 220.50 ( 4) 264.00 ( .5) 
41 282 . 00 ( 4) 331 . 50 ( 4) 259 . 20 ( 5 ) 
44 190 . 50 ( 4) 228.00 ( 4) 182.00 (3) 
47 238 . 00 ( 3) 223.50 ( 4) 256 . 50 ( 4) 
50 262 . 00 (3) 238 .00 ( 3) 248.00 (3) 
54 241 • .50 ( 4) 276 . 00 ( 4) 190 . 00 ( 3) 
57 282.00 ( 4) 261.00 ( 4) 249.00 (2) 
61 241 . 50 ( 4) 225.00 ( 4) 2.58 . 00 (2) 
64 298.50 ( 4) 228 . 00 ( 3) 249 . 00 ( 2) 
asGOT report ed in Sigma- Frankel Units . 
bTotal number of birds used . 
Tabl e 2J. Comparison of t ot al serum protein values of three 
groups of turkeys during the experimental period 
Days Post- Group Numbers 
infection 1 2 J 
6 2 .63a (4)b 2 . 50 ( 3) 2 . 96 (.5) 
13 2 . 60 ( 4) 2 . 17 (3) 2 . 50 (.5) 
16 2 .97 ( 4) 2 . 88 ( 4) 3.10 (5 ) 
23 3 . 32 ( 4) 3 . 27 ( 4) 3.50 (5) 
27 3 . 50 ( 4) J . 47 ( 4) J . 56 (5) 
30 3 . 50 ( 4) J . 47 ( 4) 3 . 52 ( .5) 
35 2 . 77 ( 4) 3 . 32 (4) J.22 (.5) 
37 2 .45 ( 4) J.00 ( 4) 3.16 ( 5 ) 
41 3 . 15 ( 4) 3 .25 ( 4) 4.54 (.5) 
44 4.80 ( 4) 3 . 75 ( 4) 4.42 (.5) 
47 4 . 90 ( 4) 4 . 27 ( 4) 4 . 42 (5) 
.50 4 . 80 ( 4) 4 . 90 ( 4) 4.47 ( 4) 
54 4.67 (4) .5 . 97 ( 4) 4 . 2J ( 3) 
57 4 . 90 ( 4) 6 . 92 ( 4) 4 . 2.5 ( 2) 
61 4.17 ( 4) 5.87 ( 4) 4.45 ( 2) 
64 4 . 2.5 ( 4) 5 . 40 ( 3) 4 . 70 (2) 
aR epor t ed a s gra.ms /100 ml . of s erum. 
bTotal number of birds used . 
F1gure 44. Progress1ve changes 1n t otal serum protein in the following groups in 
Trial I I : 
Group 1 - I mmune-control. 
Group 2 - I mmune-challenged. 
Group 3 - HN2-treated . 
Infect1on at 7 days of age 
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Table 24. Comparison of total serum albumin concentration in 
three groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
infection 1 2 :2 
6 1 . 04a (4)b 1.05 (3) 1.19 ( 5) 
( 39. 58)C (41.86) (40.28) 
13 0. 87 ( 4) 0 .27 ( 3 ) 0 . 62 (5) 
(33.11) (12 . 67) (24.46) 
16 1.09 ( 4) 0.80 (4) a . SJ (5) 
(36 .92 ) (27 . 63) (27.27) 
23 1.37 ( 4) 1.18 ( 4) 1.J9 ( 5) 
(40 .98) (J6.J1} (J9.94) 
27 1.46 ( 4) 1 . J4 (3) 1.52 ( 5) 
(41.74) (37. 08) (42 . 81) 
30 1.47 ( 4) 1.34 ( 4) 1.46 (5) 
(41 . 95) (38 . 30) (41 .56) 
35 1.09 ( 4) 1.33 ( 4) 1.24 (5) 
(J8.06) (39. 86) (37.83) 
37 0.80 ( 4) 1 . 13 ( 4) 0.76 (5) 
( .31. 88) (36 .59) (23.96) 
41 0.29 ( 4) 1 . 10 ( 4) 0.87 (5) 
(9.54) (34.76) (18.62) 
44 0.78 ( 4) 1 . 09 (4) 1.00 (5) 
(16 .76 ) (30.01) (22 .16) 
47 1.34 ( 4) 0 . 89 ( 4) 0 .96 (5) 
(27.31) (23.48) (21 . 24) 
50 1 . 63 ( 4) 0.91 ( 4) 1.06 ( 4) 
(33 .94) (18 .58) (22 . 82) 
54 1 . 61 ( 4) 1.25 ( 4) 0.84 (2) 
(34.55) (21.27) (19 . 26) 
57 1 .47 ( 4) 1.86 ( 4) 1.64 (2) 
(31 .18) (26 . 81) (38 .44) 
61 1.60 ( 4) 1 . 90 ( 4) 1.58 (2) 
(JS.36) (32 . 34) (35.67) 
64 1.45 ( 4) 2.11 ( .3) 1.98 (2) 
(32.96) (39.12) (42.14) 
aReported as grams percent. 
bTotal number of birds used. 
CReported ~s relative percent. 
F1 gure 45. Progress1ve changes 1n serum album1n concentrat1on (expressed 1n grams 
per cent) for the follow1ng groups 1n Tr1al I I : 
Group 1 - Immune-control . 
Group 2 - Immune-challenged. 
Group 3 - HN2-treated. 
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Figure 46. Progressive changes in serum albumin conoentrat1on (expressed as per 
cent of the total serum protein) 1n the following groups in Trial J I: 
Group 1 - Immune-control. 
Group 2 - Immune-challenged. 
Group 3 - HN2-treated. 
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Table 25. Comparison of total serum alpha 1 globulin concen-
tration in three groups of turkeys during the ex-
perimental period 
Days Post- Group Numbers 
infection 1 2 2 
6 0 .27 a 0.28 0.28 
(10.39)b (11.55) (9 .39 ) 
13 0.37 0 .31 0 . 36 
(14.59) (14.26) (14.61) 
16 0.27 0 . 20 0.26 
(9.25) (6.84) (8 .20) 
23 0.31 0 . 24 0 . 28 
(9.47) ( 7. 32) (7.96) 
27 0.31 0.25 0 .31 
(8.75) (6.82) (8.85) 
30 0.35 0.31 0 .25 
(9.93) (9.00) (7.10) 
35 0.26 0.29 0 . 24 
(9.50) (8.57) (7.52) 
37 0.13 0.27 0 .29 
(5.J8) (9.07) (9.13) 
41 0.26 0.28 0.26 
(8.81) (8 .45 ) (5.69) 
44 0.36 0 . 26 0 . 28 
(7.66) (7.17) (6.62) 
47 0 .27 O. JO 0 .20 
(5.64) (7.37) (4.67) 
50 0 . 19 0.32 0 .28 
(4 . 11) (6.72) (6.24) 
54 0.27 0 .26 0 .36 
(5 .99 ) (4.66) (9 .38) 
57 0.19 o.45 0 .34 
(4 . 04) (6.48) (8.00) 
61 0.32 0. 35 0 .25 
(7.66) (5.74) (5.56) 
64 0 . 29 o . 43 0 .25 
( 6 . 72) CZ • Z2) (,2 • .27~ 
aReported as grams percent . 
~eported as relative percent . 
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Table 26 . Comparison of total serum alpha II globulin con-
centra ti on of three groups of turkeys during the 
experimental period 
Daya Post- Group Numbers 
infection 1 2 3 
6 o.42 a 0.39 o.44 
(16 . 04)b ( 15. 72) (14.84) 
13 0 . 53 0.65 o . 64 
(20 . 56) (29 . 88) (25 . 75) 
16 0 .50 0.58 0.50 
(16 . 8J) (20.14) (16 . JO) 
2J o.47 o .45 0. 50 
(14 . 19) (1J . 80) (14.18) 
27 0. 50 0.54 o . 47 
(14.J6) (14 . 85) (1J . J1) 
JO 0.50 o . 46 0 . 51 
(14 . 16) (1J . 11) (14 . 54) 
35 0.50 o . 45 0. 58 
(18 . 94) (lJ . 68) (18 . 86) 
37 0 . 62 0. 56 0 . 81 
(25. 69) (19 . 55) (26 . 10) 
41 0 . 71 0.51 0 . 87 
(23 . 23) (15 . 26) (19.JJ) 
44 0.59 0 . 65 0 . 92 
(12.54) (17 . 72 ) (20 . 57) 
47 0 . 71 0 . 72 1 . 08 
(14 . 4J) (17.11) (24 . 08) 
50 o.66 0 . 91 1.00 
(lJ.71) (18 . 67) (22.0J) 
54 0.71 0.97 0 . 92 
(14 . 99) ( 16 . 52) (23.81) 
57 0.69 0. 99 o . 68 
(14 . 18) (14.21) (16 . 08) 
61 0. 56 1.00 0 . 86 
( l J . 46) (17 . 54 ) (19 . 01) 
64 o . 68 0. 95 O. SJ 
(15 .55) (17 . 87) (17 . 70) 
aReported as gr ams percent. 
bneported as r elative percent. 
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Table 27. Comparison of total serum beta globulin concen-
tration of three groups of turkeys during the ex-
perimental period 
Days Post-
infection 
6 
1J 
16 
23 
27 
JO 
J5 
37 
41 
44 
47 
.50 
54 
57 
61 
64 
1 
0.72 a 
(27 . 0B)b 
0.51 
( 19. 52) 
o . 68 
(22.80) 
0 . 57 
(17 . 14) 
0. 74 
(21.00) 
0 . 70 
(20 . 06) 
0.59 
(21.77) 
o . 64 
(26.1 8) 
O.BJ 
(26.68) 
1.07 
(22 . 40) 
0 . 89 
(18 . 07) 
0.88 
(18 . J5) 
0.82 
(17.57) 
0 . 83 
(16.99) 
0 . 89 
(21 . 42) 
0.72 
(16.75) 
Group Numbers 
2 
0 . 59 
(2J.20) 
o.66 
(J0.65) 
0.70 
(24.22) 
0. 55 
(16.85) 
0.76 
(21.22) 
o . 66 
(19.07) 
0.71 
(21.49) 
0.65 
(21.79) 
0.74 
(22.91) 
0.88 
(2J.71) 
0.88 
(20.85) 
0.98 
(20.01) 
1 .01 
(17 . 16) 
1 .J6 
(19 . 62) 
1.04 
(17.51) 
1 . 09 
(20.26) 
aReported as grams percent. 
~eported as relative percent. 
3 
0.79 
(26 . 42) 
0.61 
(24.J4) 
0.74 
(24.40) 
o.6J 
(18.30) 
0.73 
(20.4.5) 
0 . 71 
(20 . JJ) 
0.70 
(22 .12 ) 
0 . 85 
(27 .Jl) 
1 . 07 
(2J.7J) 
1 . 06 
(2J.88) 
1 . 01 
(2J.15) 
1.00 
(22.38) 
0.90 
(22.7J) 
0.85 
(20 . 0.5) 
0 . 96 
(21.64) 
0 . 88 
(18.75) 
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Table 28. Comparison of total serum gamma globulin concen-
tration of three groups of turkeys during the ex-
perimental period 
Days Post -
infection 
6 
13 
16 
23 
27 
JO 
35 
37 
41 
44 
47 
50 
54 
57 
61 
64 
1 
0 .18 a 
(6 . 9o)b 
0 . 32 
(12 . 22) 
o . 43 
(14.21) 
0 . 61 
(18 .22 ) 
0 . 50 
(14 . 16) 
o . 48 
(1J . 90) 
O.J4 
(11 . 74) 
0 . 26 
(10 . 88) 
1 . 05 
(31 . 74) 
1 . 99 
(40 . 64) 
1 . 69 
(34.55) 
1.44 
(29 . 89) 
1 . 27 
(26.90) 
1 . 72 
(JJ . 61) 
0 . 80 
(19 . 11) 
1.11 
(28 . 02} 
2 
0 . 19 
(7 .68) 
0 . 27 
(12.53) 
0 . 61 
(21 . 16) 
0.85 
(25.71) 
0 . 72 
(20 . 0J} 
0 . 71 
(20 . 52) 
0 . 54 
(16 . 39) 
0 . 39 
(13 . 00) 
0 . 63 
(18 .61) 
0 . 87 
(21 .J8) 
1 .48 
(31 . 20) 
1. 78 
(36 . 02) 
2 .49 
(40.JB} 
2 . 28 
(J2.88) 
1 . 58 
(26 . 87) 
0 . 83 
(14 . 96) 
aReported as grams percent. 
~sported as relative percent. 
3 
0 . 27 
(9 . 06) 
0. 27 
(10 . 84) 
0 . 76 
(2J . 84) 
0 .70 
( 19 . 62) 
0 . 53 
(14.57) 
0 . 59 
(16 . 47) 
o . 46 
(lJ . 67) 
o . 45 
(1J . 50) 
1 . 47 
(J2 . 6J) 
1 . 16 
(26 . 77) 
1 . 17 
(26 . 86) 
1 . 13 
(26 . 52) 
0 . 98 
(24 . 83) 
0 . 74 
(17 . 43) 
0 . 80 
(18 . 13) 
0 . 75 
(16 . 04) 
Figure 47. Progressive changes 1n serum gaC!l!!la globul1n concentrat1on (expressed 
in grams per cent) for the follow1ng groups in Trial II : 
Group 1 - Immune-control . 
Group 2 - Immune-challenged. 
Group 3 - HN2-treated . 
Infection at 7 days of age 
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Groups 1 and 2 (Figure 44 ) . Signi f i cant changes were ob-
se r ved in both serum albumin and gamma globulin fractions 
(Figur es 45, 46 , 47, 48) . Changes in other protein f racti ons 
wer e not r emarkable . 
Histopathologi c Studies 
Group 1 - immune-control birds 
Birds in this group did not have either gross or mi cro-
scopi c lesions referable to histomonosis. Focal areas of 
lymphoid cell a ccumulations ( s i milar t o those descri bed in 
Trial I) were numerous in t he liver, ceca l mucosa, s pleen , 
and were occasi onally seen i n bronchial and intestinal mucosa. 
Group 2 - immune-challenged birds 
Gross oecal lesions were present in only 2 birds. 
Other birds in this group, did not have gross lesions either 
in the liver or ceca. 
Liver lesions H1stopathologic alterations were con-
fined to 2 liver sections and consisted of discrete areas 
of resolving lesions. No h1stomonads were found in these 
a r eas. 
Cecal l esions Microscopic examination of ceca with 
gross lesions revealed large numbers of polymorphonuol ear 
leukocytes in the mucosa and submucosa . Giant cell s contain-
ing degenerated for ms of hlstomonads were present in these 
areas. Sections from ceca free of gross lesions we re his-
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tologically similar to those descr ibed in Group 2, Trial I. 
Lesions in other tissue s Lesions in other tissues 
were not remarkable and closely paralleled. those described 
in Group 2 of Trial I. 
Group 1 - HN2-treated birds 
Gross lesions were present in livers of 3 of the 5 birds. 
Lesions in the other 2 birds were restricted to the ceca. 
Liver lesions Microscopi c liver lesions consisted of 
large necrotic areas with i rregular borders. Macro~hages, 
multinucleated g iant cells and many histomonads were present 
in these a r eas. Frequently, giant cells contained one or 
mo~e h1stomonads . A mild mononuclear cell infiltrate was 
present at the periphery of these necrotic areas. Sections 
from livers without gross lesions had a few focal resolving 
lesions. 
Cecal lesions Microscopic cecal lesions were similar 
to those described for Group 3, Trial I. 
Lesions in other tissues Marked lymphoid depletion 
was observed in the spleen (Fi gures 32 and 33) and the bursa 
of Fabricius (Figures J4 and 35). The histopathologic alter-
ations found in the lungs, kidneys and small intestine were 
not r emarkable. 
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Trial III 
Mortality 
Mortality rates in Groups 1, 2, 3, 4, and 5 were 0/5, 
0/6 , 1/7, o/6, and 2/5, respectively. 
Body Weights 
Result s of body weight gains were similar to those re-
por ted for Trial I and are summarized in Table 29 . Slight 
weight gain depressions were evident in Groups 3 and 4 
following treatment with HN2 (Figure 49). 
Hematologic Observations 
Total leukocyte counts 
Detailed results of the total leukocyte counts for the 
5 groups are given in Table 30 . No significant changes in 
total leukocyte counts were detected in Group 1, which con-
sisted of uninfected control birds. In general, the average 
total leukocyte counts varied between 16,000 and J 0 ,000 
cells/cu. mm . 
The leukocyte response pattern in infected groups (Groups 
2, J, and 4) was similar to that observed in Trial I. All 
groups except Group 1, had a marked increase in leukocytes 
following challenge with virulent histomonads (Figure 50) . 
Differential leukocyte counts 
The resul ts of differential leukocyte count& are s um-
Table 29. Comparison of average weights ( in grams) of five 
groups of turkeys during the experimental period 
Days Post- Group Numbers 
infection 1 2 2 
14 a (o)b 137 (4) 131 (3) -17 ( 0 ) 154 ( 4 ) 157 (3) 
21 1b'5 (5) 185 ( 4) 182 (3) 
24 193 (5) 204 ( 4) 215 (3) 
28 231 ( 5) 245 ( 6) 223 (7) 
31 274 (5) 306 (6) 270 (7) 
35 330 (5) 384 (6) 333 (7) 
38 365 (5) 452 ( 6) 370 ( 7) 
42 442 ( 5) 523 (6) 412 (7) 
45 513 ( 5) 600 ( 6) 495 (7) 
49 593 ( 5) 663 (6) 564 ( 7) 
52 662 ( 5) 666 ( 6) 549 ( 7 ) 
56 783 (5) 723 ( 6) 617 ( 6) 
aNo weights recorded . 
bTotal number of birds used . 
Table J O. Comparison of average total leukocyte counts of 
five groups of turkeys during the experiment al 
period 
Days Post- Group Numbers 
infection 1 2 1 
14 a (O)b 31,050 (4) 35 . ?00 (3) 
17 - (0) 29,800 ( 4) 21 , 050 (J) 
21 23 ,JOO (5) 28 , 050 ( 4) 23 , 050 (3) 
24 26 , 450 (5) 20,950 ( 4) 19 , 950 (3) 
28 16 , 400 ( 5) 25,000 ( 6) 23,950 ( 7) 
31 23 ,650 ( 5) 21 , 750 ( 6) 26,700 (7) 
35 21,550 ( 5) 22,650 ( 6) 19 , 800 ( 7) 
JS 19 , 800 ( 5) 15 ,450 ( 6) 9.850 ( 7) 
42 27,J50 ( 5) 16 , 900 ( 6) 12,1 00 ( 7) 
45 24,250 ( 5 ) 20,600 (6) 15 ,450 (7) 
49 33.750 ( 5 ) 32,700 ( 6) 30 ,500 (7) 
52 21,800 (5) 48,550 (6) 38 , 000 ( 7) 
56 28,600 (5) 50,300 (6) 50,650 ( 6) 
aNo samples recorded. 
bTotal number of birds used . 
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11 7 ( 4) - (0) 137 (4) 
187 
(0) 
154 ( 4) ( 5) 
177 (4) 216 . (5 ) 
223 (6) 258 (5 ) 
273 (6) 306 ( 5) 
333 ( 6 ) 374 ( 5) 
381 (6) 425 (5) 
470 (5) 509 (5) 
491 ( 6) 598 (5) 
49R ( 6) 679 (5 ) 
500 (6) 729 ( 5) 
463 (6) 830 ( 4) 
4 
56,500 ( 4) - (0) 23,500 ( 4) (0) 
23,350 ( 4) 23,'boo (5) 
20 ,950 ( 4) 23,600 (5) 
18,350 ( 6) 20,600 (5 ) 
21,550 ( 6) 24 , 950 (5) 
18 , 150 (6) 19 . 950 (5) 
21,800 (6) 27,600 (5) 
28,250 (5) 2 7, 100 (5) 
25,000 ( 6) 32,600 (5) 
36,950 (6) 30,350 (5) 
31,700 (6) 39.900 (5) 
41,600 ( 6) 54,500 ( 4) 
Fi gure 49 . Progressive changes in the body weights of the following groups in 
Trial III: 
Group 1 - Uninfected-control . 
Group 2 - Immune-challenged . 
Groups J and 4 - HN2-treated. 
Group 5 - Infected-control . 
Infection at 7 days of age 
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marized in Tables 31 through 35. Changes in total leuko-
cyte counts were reflected in absolute heterophil numbers 
(Figure 51). Marked heterophilia was observed in all infect-
ed groups before treatment with dimetridazole (Figures 51 and 
52). Heterophil numbers below 6,000 cells/cu. mm. were seen 
in Group 3 which was being treated with HNz. After challenge, 
the absolute heterophil numbers were markedly increased in 
all gToups except the control group (Figure 51). 
The lymphocyte response pattern in all the groups except 
G1oup 3 was similar to that of the control group (Figures 53 
and 54). In Group 3. total lymphocyte numbers fell below 
control levels following treatment with HN2 . Total lympho-
cyte numbers above control values were observed in Group 5 on 
the day the experiment was terminated (Figure 53). 
Changes in other cell types were not remarkable. A 
twofold increase in eosinophils was found in Group 5 on the 
last day of the experiment. One bird in this group had a 
marked eosinophilia (total eosinophil count of over 2,900 
cells/cu. mm.) on this day, which was reflected in the high 
average total eosinophll count for the whole group. There was 
an increase in total number of monocytes 1n all groups except 
Group 1, in the terminal stages of the experiment. Basophlls 
accounted for 3 to 6 per cent of the total leukocyte counts 
in all groups. 
Table 31. Comparison of average total heteroph11 counts of 
five groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
infection 1 2 3 
14 a (66 . 25)b {68.00) 
21,450 c 24,150 
17 (55 . 00) (49.00) 
16,600 10,550 
21 (54.80) (52.00) (55.67) 
12,850 14,700 13,050 
24 (49 . 20) (53 . 50) (51.33) 
13,200 11,250 10,400 
28 (50.40) (49.50) (40.86) 
8,200 12,100 9.950 
31 (55.00) (56 . 17) (50.14) 
13,750 12,100 14,050 
35 (47 . 20) (44.00) Un . 57) 
10,450 9,650 9,650 
38 (41 . 40) (47 . 17) (56.00) 
8,350 7 , 350 5,400 
42 (39.60) (43.33) (43.71) 
10,850 7 , 100 5,800 
45 (JJ . 60) (42.00) ( 32. 71) 
8,400 8,950 6,000 
49 (41.RO) (60.50) (47.29) 
14,R50 20,550 16,000 
52 (35.20) (62.50) (59.29) 
7,600 31,600 22,800 
56 (48.40) (59.00) (61.17) 
13,800 31,650 34, 150 
aNo samples recorded. 
'biieported as percentage. 
0Reported as total numbers of cells/cu. mm. 
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4 
(75 . 50) 
43, 150 
(44 . 00) 
10,400 
(54. 25) (52 . 60) 
12,650 12, 2 50 
(50 .75) (46.40) 
10,750 11,100 
(40.33) (49 . 00) 
7,450 10,450 
' 
(47 . 17) (41 . 20) 
10 ,150 10,600 
(39 -33) (40 . 40) 
7,450 8,150 
(43 . 33) (45.60) 
9,650 13 , 350 
(48 . 40) (44.20) 
15,050 12,000 
( 52. 1 7) (39.40) 
14,700 13, 150 
(74. 83) (40 . 00) 
25,750 12,300 
(61 .83) (50.40) 
21,000 23,100 
( 54 . 17) (46 . 75) 
22,050 25,450 
Figure 51. Absolute numbers of heterophils in the following groups i n Trial I II : 
Group 1 - Uni nfected-control . 
Group 2 - Immune-challenged. 
Groups 3 and 4 - HN2-treated. 
Group 5 - Infected-control. 
I nfection at 7 days of age 
(/) 
e:::: 
w 
40 
35 
~§ 
::::> 0 30 
z_J 
i:Q 
_J 
-.LL 
:co 2 
a_ -
0 :IE 
e:::: :iE: 
w 
I- -~B 20 
w ' I- (/) 
::::> 0 
6 ~ 15 
(/) (/) ~~ 
w I- 10 ~== 
w 
> 
<( 
5 
TRIAL III 
o GROUP ONE 
A GROUP TWO 
GROUP THREE 
• GROUP FOUR 
o GROUP FIVE HN2 TO HN2 TO 
GROUP 3 CHALLENGE GROUP 4 
I 
I 
I 
I 
o--~..__~~~-L-~-L-~-'---Z---Z-~~~.JL.J..~--'-~___._~---'~ 
21 25 29 33 37 41 43 4S 49 5253 57 61 65 
AGE OF BIRDS, IN DAYS 
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Group 1 - Uninfected-control. 
Group 2 - Immune-challenged. 
Groups 3 and 4 - HN2-treated. 
Group 5 - Infected-control. 
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Table 32. Comparison of average total eosinophil counts of 
five groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
infection 1 2 ~ 4 .2 
14 a (o.75)b (0.33) (0.25) 
212 c 135 166 
17 (0.33) (1.50) 
62 369 
21 (0 .20) (0.25) ( 1. 00) (0.25) (0.00) 
31 96 183 44 0 
24 (0.60) (0.25) (0.33) (0 . 25) (0.60) 
180 50 53 63 158 
28 (0.00) (0.33) (0.86) (0.00) (0.00) 
0 69 243 0 0 
31 (0.00) (0.33) (0.71) (0.50) (0.40) 
0 81 162 79 112 
35 (0 .20) (0.00) (0.14) (0 .00) (0.20) 
3 0 21 0 36 
38 (0.00) (0.00) (0 . 14) (0 .00) (0.00) 
0 0 15 0 0 
42 (0.20) (0.83) (0.43) (0.20) (0.20) 
42 132 59 50 60 
45 (0 . 00) (0.17) (0.29) (0.17) (0.00) 
0 33 57 22 0 
49 (0 . 00) (0 . 00) (0.00) (0.33) (0.20) 
0 0 0 102 64 
52 (0.00) (0.00) (0 . 00) (0.17) (0 . 00) 
0 0 0 119 0 
56 (1.20) (0.17) (0.33) (0.00) (1.25) 
391 158 165 0 732 
a No sample recorded. 
°hReported as percentage . 
0 Reported as total numbers of cells/cu. mm. 
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Table 33. Comparison of average total monocyte counts of five 
groups of turkeys during the experimental period 
Days Post- Group Numbers 
infection 1 2 2 4 ~ 
14 a (o.75)b (0 . 67) (0.25) 
212 c 270 228 
17 (0 . 00) (0 . 33) (0 . 75) 
0 87 193 
21 (0 . 00) (0 . 75) (0.00) (0 . 25) (0.40) 
0 214 0 44 100 
24 (0 . 80) (0.25) (0 . 33) (0 . 25) (0.40) 
188 58 53 63 119 
28 (0.40) (0.33) (1.43) (0.67) (0 . 00) 
63 99 361 121 0 
31 (0 . 40) (0 . 00) (0.29) (0 . 33) (0 . 20) 
135 0 93 54 36 
35 (0 . 40) (0 . 50) (0 . 57) (0 . 33) (0 . 60) 
79 119 95 47 133 
JR (0.00) (0 . 17) (0 . 29) (0 . 17) (0 . 80) 
0 21 44 40 233 
42 (0 . 00) (0 . 17) ( 1 . 14) (0 . 60) (0 . 20) 
0 30 135 140 59 
45 (0.60) (0.67) (0.71) (0 . 00) (0 . 00) 
136 119 61 0 0 
49 (0 . 40) (0 . 33) (0 . 43) (0 . 33) (1 . 00) 
170 120 105 42 320 
52 (0 . 60) (2.50) (1.14) (1.50) (0.60) 
134 1,007 392 567 187 
56 (0 . 20) (0 . 67) (1.83) (1 . 50) (0 . 75) 
69 484 1,018 529 425 
aNo samples recorded . 
'bi1eported as percentage. 
0 Reported as total numbers of cells/cu . mm . 
Table 34. Comparison of average total lymphocyte counts of 
five groups of turkeys during the experimental 
period 
Days Post- Group Numbers 
inf action 1 2 3 
14 a (29.25)b (29.JJ) 
8,150 c 10,600 
17 (42.75) (47.00) 
12,500 9,750 
21 (42.20) (41.75) (40.33) 
9,850 11,550 9,200 
24 (45.60) (41.25) (43.67) 
11,950 8,600 8,550 
28 (46.00) (45.17) (51.57) 
7.550 11,500 12,150 
31 (42.40) (39.67) (45.57) 
9,400 8,650 11,550 
35 (47.20) (51.83) (47.29) 
9,900 12,150 9,200 
38 (55.60) (48.17) (37.43) 
10,800 7,500 3,750 
42 (55.20) (49.JJ) (46.4)) 
15,200 A,700 5,100 
45 (60.40) (52.00) (6).43) 
14,400 10,350 8,850 
49 (55.20) (34.83) (50.29) 
17,850 10,850 13,850 
52 (60.40) (32.50) (36.71) 
13,200 15,000 13,600 
56 (46.00) (3?.17) (33.67) 
13,100 16,950 14,200 
aNo sample recorded. 
'biieported as percentage. 
Cfieported as total numbers of cells/cu. mm. 
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( 24. 2 5) 
13,050 
(50 . 25) 
11,R50 
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9,350 
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9,700 
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10,100 
(54.83) 
9,650 
(53. 00) 
11,300 
(44 .40) 
11,450 
(42 . 83) 
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(20.83) 
10,200 
(33.50) 
9.350 
(41.67) 
17,850 
( 42 . 2 0) 
10,100 
( 48 .2 0) 
11,150 
(48.40) 
9,600 
(54 . 80) 
13,400 
(55 . 20} 
11 , 000 
(42 . 20) 
12,400 
(48 . 40) 
13,100 
(56 . 60) 
18,150 
(54.20) 
16,200 
(44.40) 
15,000 
(43.25) 
23,250 
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Figure 53. Absolute numbers of lymphocytes in the following groups in Trial III: 
Group 1 - Uninfected-control. 
Group 2 - Immune-challenged. 
Groups 3 and 4 - HN2-treated . 
Group 5 - Infected-control . 
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Figure 54. Relative numbers of lymphocytes (expressed in per cent) for the 
following groups i n Trial III : 
Group 1 - Uninfected-control. 
Group 2 - I!Ilfilune-challenged . 
Groups 3 and 4 - HN2-treated. 
Group 5 - Infected-control. 
Infection at 7 days of age 
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Table 35. Comparison of average total basophil counts of five 
groups of turkeys during the experimental peri od 
Days Post- Group Numbers 
infection 1 2 ~ 4 2 
14 a (3.oo)b (1.67) {2.25) 
1,008 c 554 1,580 
17 (2.25) (3.33) (3.75) 
736 617 804 
21 (2 . 80) (5 . 25) (3.00) (4.75) (4.80) 
594 1,476 597 1,040 1,119 
24 (3.80) (4 . 75) (4.33) (3 . 50) (4.40) 
926 980 900 729 1,045 
28 (3 . 20) (4.67) (5.57) (5 .83) (2 . 60) 
558 1,213 1,345 1 , 073 528 
31 (2 . 20) (3.83) (3.29) (5.33) (3.40) 
429 853 841 1,170 777 
35 (5 . 00) (3.67) (4.43) (5.50) (3.60) 
1,135 772 828 965 684 
JR (3 . 00) (4.50) (5.29) (3.50) (5 . 40) 
644 621 600 741 1,634 
42 (5.00) (6 . 33) (8.29) (6.40) (7 . 00) 
1,277 954 1,002 1,532 1,890 
45 (5.40) (4.17) (2.86) (4.83) (4.00) 
1,339 723 502 765 1,312 
49 (2,60) (4.33) (2.00) (J.67) (4 . 60) 
918 1,200 555 818 1,462 
52 {J.80) (2 . 50) ( 2. 86) (J . 00) (4.60) 
835 941 1,201 619 1,579 
56 (4.20) (3.00) (J.00) (2 . 67) (7.75) 
1,215 1,043 1,128 1,177 4,523 
a No samples recorded. 
bReported as percentage. 
cReported as total numbers of cells/cu. mm . 
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SGOT Values 
Results of SGOT analyses are given in Table 36 . Changes 
in SGOT values were not remarkable in any one group. Some 
sick birds had elevated SGOT levels but this was not reflect-
ed in the mean value for the group. 
Serum Protein Studies 
Results of serum protein determinations are given in 
Tables 37 through 42. No significant changes were detected 
in the total serum pr otein levels among all g r oups (Figure 
55). Changes in albumin and globulin fractions in all infect-
ed groups were similar to those described for Trial I (Figures 
56. 57. 58, 59). However, gamma globulin levels in Group 5 
(infected at the day of challenge) did not differ significant-
ly from those of the uninfected control group (Group 1) (Fig-
ures 58 and 59). 
Histopathologic Studies 
Group 1 - uninfected-control birds 
All birds in the group were killed at the end of the 
trial and no gross lesions were observed. On microscopic 
examination small necrotic foci were found scattered through-
out the liver parenchyma. Coagulative necrosis had occurred 
without cellular response. No significant microscopic lesions 
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Table 36. Compar ison of serum glutamic-oxalacetic trans-
aminase (SGOT) activity of five groups of turkeys 
during the experimental period 
Days Post- Grou12 Numbers 
infection 1 2 J 4 .2 
14 a 252. oob 318.00 358 . 00 
17 204.oo 240 . 00 250 . 50 
21 304-:-80 268 . 50 324. oo 282 . 00 300-:-00 
24 277.50 292 . 50 298 . 00 336 . 00 250 . 00 
28 262 . 00 267.00 251.00 249 . 20 285 . 00 
31 290 . 00 218.00 223.29 209 . 33 249 . 00 
35 267 . 00 206 . 00 211 . 71 189 . 00 204 . oo 
38 258 . 00 231.00 220 . 00 212 . 00 190 . 50 
42 258 . 00 254 . oo 213.43 184 . 80 226.80 
45 240.00 248.00 207 . 43 199 . 20 204 . oo 
49 282.00 217.67 202 . 29 187 . 00 207 . 00 
52 255 . 60 2 33 . 33 284 . 71 314 . oo 207 .20 
56 277 . 20 217.00 274 . 00 356 . 00 226 .50 
aNo samples recorded . 
bsGOT r eported in Sigma- Frankel Units . 
Table 37 . Comparison of total serum protein values of five 
groups of turkeys during the experimental period 
Days Post- Group Numbers 
infection 1 2 ~ 4 2 
14 a 2 . 47b 2 . 67 2 . 27 
17 3 . 17 3 . 87 2 . 97 
21 2-:-RS 3 . 15 3 . 20 3 . 15 2-:-s4 
24 3 . 00 3 . 25 3 . 17 3 . 35 2 . 76 
28 3 . 00 J . 47 3 . 36 3 . 27 J . 08 
31 J .12 3 . 33 3 . 07 3 . 13 J . 02 
35 2 . 98 3 . 27 J . 06 2 . 95 2 . 90 
JR 3 . 14 J . JO 3.55 3 . 33 3 .14 42 3 . 16 2 . 5R 2 . 86 2 . 80 2 . 74 
45 3 . 24 3 .1 0 3 . 17 2 . 90 J . 12 
49 3 . 02 3.05 J . 04 2 . 87 3 . 54 52 J . 04 3 . 52 2 . 8J 2 .73 2 . 64 
56 3 . 64 4.63 3.85 J . 47 J.45 
aNo sample s recorded. 
bReported as grams/ 100 ml. of serum . 
Figure 55. Progressive changes 1n total serum protein 1n the following groups in 
Trial III: 
Group 1 - Uninfected-control. 
Group 2 - Immune-challenged . 
Groups J and 4 - HN2-treated. 
Group 5 - Infected-control. 
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Table 38 . Compari s on of total serum albumin concentration of 
f i v e groups of turkeys during the e x per i mental 
period 
Days Post- Group Numbers 
infection 1 2 J 4 .2 
14 a o . 43 b 0. 73 0 .62 
(17 . 25)C (27 . 22) (25 . J8) 
17 0 . 58 1. 02 0 . 80 
(18.80) ( 25 . 72) (26 . 86) 
21 1 . 21 0 .90 1.10 1.06 1 . 18 
(42 . 04) (28 . 68) (34.56) (33 . 58) (41.53) 
24 1.38 1.02 1.24 1.32 1 . 15 
(46.23) (31.44) (39.36) (39.24) (41.70) 
28 1 . 32 1.40 1.39 1.49 1 . 29 
(44 . 23) (40 . 62) (41.17) (45 . 45) (42 . 01) 
31 1 . 47 1.44 1.31 1 . 45 1.44 
(47 . 74) (42.80) (42 . 45) (45 . 97) (48 . 07) 
35 1 . 47 1.40 1.25 1 . 31 1 .31 
(49.21) (42.70) (40 .84) (44 . 58) (45 . 66) 
38 1 . 39 1 . 65 1.55 1 . 48 1 . 36 
(43 . 66) (48 . 25) (43 .47) (44 . 32) (43 . 27 ) 
42 1 . 38 1 .10 1.23 1 . 26 1 . 27 
(44. 59) (42 . 63) (42 . 75) (45 . 52) (46 . 56) 
45 1 . 49 1 . 30 1.14 1 .24 1 . 32 
(43 . 86) (41.65) (35 . 81) (42 . 54) (42.77) 
49 1 . 28 1 . 13 0 . 95 1 . 04 1 . 19 
(4J.21) (J6.59) (31.27) (J5.70) (36.37) 
52 1 . 16 1 . 03 0.74 0.71 0 . 87 
(39.15) (29 . 86) (25 . 18) (26 . 23) ( 32 .27) 
56 1 . 49 1 . 03 0.77 0.39 1.27 
(41.06) (22.40) (21.33) (12 .98) (36 . 98) 
aNo sample s recorded. 
~eported as grams percent . 
cReported as relative percent. 
Figure 56. Progressive changes in serum albumin concentration (expressed in grams 
per cent) for the following groups in Trial II I : 
Group 1 - Uninfected-control. 
Group 2 - Immune- challenged . 
Groups 3 and 4 - HN2-treated. 
Group 5 - Infected-control. 
Infection at 7 days of age 
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Figure 57. Progressive changes in serum albumin concentration (expressed as per 
cent of the total serum protein ) 1n the following groups 1n Trial III: 
Group 1 - Uninfected-control . 
Group 2 - Immune-challenged. 
Groups 3 and 4 - HN2-treated. 
Group 5 - Infected-control. 
Infection at 7 days of age 
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Table 39. Comparison of total serum alpha 1 globulin concen-
tration of five groups of turkeys during the ex-
perimental period 
Days Post- Group Numbers 
infection 1 2 2 4 5 
14 a 0 .25 b 0.11 0.15 
(8.67)C (4.10) (6 . 36) 
17 0.26 0.28 0 .25 
(8 . 03) (6 .82) (8.35) 
21 0 . 23 0.28 0.22 0 . 22 0 . 24 
(8 . 04) (8 . 84) (6.79) (6 . 96) (8 . 46) 
24 0 .21 0 . 23 0 . 23 0.25 0 .20 
(6 . 83) (7 . 23) (7.31) (7.51) (7.25) 
28 0 .21 0.22 0.21 0 . 19 0 . 23 
(7.09) (6 . 55) (6 . 42) (5 . 77) (7 .77) 
31 0.26 0 .26 0 . 21 0 . 24 0.22 
(8 .35) (8 . 13) (6 . 94) (7.73) (7 . 33) 
35 0.22 0.32 0.25 0 .23 0 . 27 
(7 . 15) (10 . 18) (8 . 32) (7 . 86) (9 .35 ) 
38 0 . 29 0 .23 0.24 0 . 24 0.28 
(9 . 10) (6 . 92) (6 . 88) (7 . 36) (9.12) 
42 0 .27 0 . 26 0 . 23 0 . 2J 0.24 
(8 . 73) (10 . 02) (8.06) (8.31) (8.80) 
45 0 . 35 0 .33 0 . 27 0 .29 0 . 35 
(10 . 56) (10.77) (8.50) (9.79) (11.04) 
49 0 .27 0 . 31 0.32 0 .20 0.38 
( 9 . 42) (10 .39) (10 . 42) (7 . 17) (10 . 83) 
52 0 .28 0 .24 0 . 25 0 . 19 0 . 26 
(9 .73 ) (7.28) (8 . 39) (7.09) (9 . 42) 
56 0.29 0 . 23 0 . 27 0 . 16 0. 25 
(8 .06) (5 . 16) (7.05) (4 . 84) (7 . 38) 
aNo samples recorded. 
°bi1eported as grams percent. 
cReported as relative percent . 
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Table 40 . Comparison of total serum alpha II globulin concen-
trat1on of five groups of turkeys during the ex-
perimental period 
Days Post- Group Numbers 
infection 1 2 2 4 5 
14 a o . 68 b 0 . 67 0 . 75 
(28 . 42)c ( 25 . 02) (31 . 40) 
17 o . 66 0 .73 0 . 50 
(20 . 86) (18 . 25) (16 . 71) 
21 0 .52 o . 64 o . 64 0 . 62 0 . 53 
(18 . 03) (20 . 14) (19.70) (19 . 71) (18.39) 
24 0. 55 0 . 61 o .48 0 . 51 0 . 54 
(17 . 99) (18 . 45) (15.29) (15.18) (19 .46) 
28 0 . 49 0 .54 0 . 57 o . 45 0 .55 
(15 . 85) (15 . 28) (17 . 08) (14 . 00) (1 7 . 67 ) 
31 0 . 41 o .4o 0 . 39 o . 45 o . 44 
(12 . 46) (12 . 33) (12.74) (14 . 39) (14 . 40) 
35 0 . 35 0 . 35 0 . 38 0 . 39 o . 4o 
(11 . 84) (10 . 51) (12 . 41) (13 . 16) (lJ . 64) 
JR o . 44 o.47 0 . 54 o . 47 o . 46 
(14 . 04) ( 14 . 02) (14.99) (14 . 09) (14 .39 ) 
42 0 . 44 0 . 34 o .42 0 . 38 0 . 34 
(13 . 70) (13 . 25) (14 . 94) (13 . 25) (12 . 47) 
45 0 . 41 0 .38 0 .41 0 . 39 0.38 
(11 . R6) (12 . 24) (12.85) (13 . 44 ) (11.93) 
49 0 . 40 0 . 4R o . 47 0 . 65 0 . 63 
(lJ . 00) (15.74) (15. 49) (22 . 57) (16 .32 ) 
52 0 . 41 0 .71 0 .56 0 . 65 0 . 41 
(13 . 16) (19 .92 ) (1R . R7) (24 . 04) (16 . 12) 
56 0 . 50 0 . 81 0 . 67 0.55 0. 52 
(13 . 57) ( 17 .24) (17 . 13) (16 . 75) (14 . 86) 
a No samples r ecorded. 
'bi1eported as grams percent . 
cReported as relative percent . 
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Table 41. Comparison of total serum beta globulin concen-
trati on of five groups of t urkeys during the ex-
perimental period 
Days Post- Gr oup Numbers 
infection 1 2 2 4 ~ 
14 a 0 .71 b 0.77 0.60 
(28.65) 0 (28.76) (24 . 93) 
17 o.68 0 . 87 o .64 
(21.22) (23.JO) (21 .44 ) 
21 0.62 o.68 0 .60 0 .65 0.60 
(21.54) (21 .58) (19.04) ( 20. 62) (21.13) 
24 0.60 0.61 o.64 o.66 0.58 
(19.97) (18.84) (20.25) (19.76) (21.02) 
28 o.64 0.60 o.66 0.65 0.67 
(21.59) (17.62) (19.88) (19.75) (21 . 77) 
31 0 .61 0.59 0.63 0 . 53 0 . 61 
(19.57) (17. A7) (20.65) (17. 06) (19. 99) 
35 0.62 o.64 o. 66 0.57 0 . 52 
(2 0 .RR) (19.75) (21.70) (1 8 .74) (17 . 80) 
JR 0.59 0 . 55 0 .73 0 .63 o.64 
( lfL 72) (1 6 .11) (20.56) (18.95) (20 .46) 
42 0 .60 o . 49 0.60 0.59 0 .53 
(18 . 87 ) (19 . 11) (21.04) (17.79 ) (19.32) 
45 0 . 73 0.5R 0.67 0.59 0.75 
(21.33) (18.73) (20 .77 ) (20 .25) (23 . 88) 
49 0.71 0.70 0. 72 0. 72 0 .88 
(22. 89) (22.85) (23.65) (25.06) (24.26) 
52 0.73 0.82 0 .76 0 . 69 0.70 
(2).60) (2J.J4) (25.94) (25 .54 ) (26.35) 
56 0 .73 0 . 84 0.78 0 . 65 0 .78 
(19.64) (18.05) (20.48) (19. 09) (22.53) 
a No samples recorded. 
~eported as grams percent. 
0 Reported as relative percent. 
163 
Tabl e 42. Comparison of total serum gamma globulin concen-
tration in five groups of turkeys during the ex-
perimental period 
Days Post- Group Numbers 
infection 1 2 :2 4 .2 
14 a o.4o b 0 . 39 0.29 
(17 . 0l) C (14 . 90) (11 .93) 
17 1 . 00 0 . 96 0 . 80 
(31.08) (25.91) (26 . 64) 
21 0 . 29 o . 66 o.64 0.60 0 . 30 
(10 .34) (20 . 76) (19.91) (19 . 13) (10.50) 
24 0 . 27 0 . 77 0.56 0.61 0.29 
(8 . 98) (24 . 04) (17.79) (18.31) (10.58) 
28 0 . 34 0 .70 0.52 o . 49 0 . 34 
(11 . 23) (19 . 93) (15 . 46) (15.0:i ) (10 . 78) 
31 0 . 38 0 . 63 0 . 53 o . 45 0.31 
(11 . 89) (18.87) (17.22) (14 . 86 ) (10 . 22) 
35 0 . 32 0 . 56 0 . 51 0 . 4) 0 . 39 
(10 . 93) (16.86) ( 16 . 72) (15 .66) (13 . 55) 
38 o . 46 0 . 50 0.49 0 . 50 o. 4o 
(14 .48) (14 . 70) (14.10) (15 . 28 ) (12.76) 
42 o . 47 0 . 38 0 . 38 o . 43 0 . 36 
(14 . 11) (14 . 99) (13.21) (15 . l :i) (12 . 86) 
45 o . 42 0 . 51 0 . 71 o . 4o 0.32 
(12 . 38) (16 . 62) (22 . 07) (13 . 98 ) (10 . 38) 
49 0.35 0 . 44 0. 58 0 . 28 o . 46 
( 11. 48) (14 . 44) (19.17) (9 . 49) (12 . 21) 
52 o.45 0. 72 0 . 62 0 . 50 o. 4o 
(14 . 37) (19.60) (21.61) (17 . 09) (15 . 84) 
56 o . 64 1 . 72 1 . 36 1.71 0.63 
(17 . 67) (37.16) ( 34. 02) (46 . 34) (18.25) 
a No samples recorded. 
bReported as grams percent. 
cReported as relative percent . 
Figure 58. Progressive changes in serum gamma globulin concentration (expressed 
in grams per cent) for the following groups in Trial III: 
Group 1 - Uninfected-control. 
Group 2 - I mmune-challenged. 
Groups 3 and 4 - HN2-treated. 
Group 5 - Infected-cont~ol. 
Infection at 7 days of age 
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Figure 59. Progressive changes 1n serum gamma globulin concentration (expressed as 
per cent of total serum protein) in the following gr oups 1n Tr1al III: 
Group 1 - Uninfected-control. 
Group 2 - Immune- challenged. 
Groups 3 and 4 - HN2 - treated. 
Group 5 - Infected-control. 
Infeot1on at 7 days of age 
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were observed in other tissues. 
Group 2 - immune-challenged birds 
All birds were killed at the end of the trial. Both 
gross and microscopic lesions were similar to those seen in 
Group 2 of Trial II. 
Group l - HN2-treated birds (-2 to +2 days pre- and postchal-
lenge) 
Cecal lesions similar to those in Group 3 of Trial II 
were observed in all 7 birds but liver lesions were found. in 
4 birds only. There was a slight lymphoid depletion in the 
spleen and much of the bursal tissue had. been replaced by con-
nective tissue. Mi croscopic changes observed in other tissues 
were not remarkable. 
Group 4 - HN2 - treated birds (.±Z to +11 days postchallenge) 
Gross lesions were present in the livers and ceca of all 
birds. 
Liver lesions Microscopic liver lesions consisted of 
massive areas of coagulative necrosis surrounded by mono-
nuclear inflammatory cells. Giant cells containing individual 
or "nested." hi stomonads were frequently seen in the necrotic 
areas and ad j acent tissue. Bile duct proliferation was quite 
marked. in less damaged portions of the liver parenchyma. 
Cecal lesions Cecal lesions were si milar to those 
seen in Grou~ J of the same trial. 
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Lesions l!l other tissues Lymphoid depletion of the 
spleen was observed in 4 out of the 6 birds used in this 
group. One bird had. a mycotic granulomatous pneumonia and 
Aspersillus ~· was present in air sacs and in thrombosed 
vessels in the lung. The bursa of Fabricius was reduced in 
size and fewer cells were present in its follicles. There 
was an increase in interfollicular connective tissue. 
Group 2 - infected-control birds 
Three birds had typical histomonosis lesions in the ceca 
and liver. Lesions in the 4th bird were confined to the ceca 
while the 5th bird had no gross lesions. 
Liver lesions The histopatholog1c alterations of 
liver sections from birds which had gross lesions, consisted 
of necrotic areas randomly scattered throughout liver par-
enchyma. There was a marked mononuclear cell infiltration in 
these necrotic areas. Macrophages and giant cells were pre-
sent in large numbers. Histomonads could be seen in some of 
the giant cells and also in disrupted hepatic sinusoids. 
Cecal lesions The cecal lesions consisted of massive 
invasion of all layers by macrophages, lymphocytes, plasma 
cells and polymorphonuclear leukocytes. Histomonads had 
penetrated all cecal layers but were most numerous in the 
lamina propria. The ceca without gross lesions were found 
to have large numbers of polymorphonuclear leukocytes in the 
wall. 
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Lesions in other tissues Microscopic changes ob-
served in other tissues were not remarkable except that in 
some birds large numbers of polymorphonuclear cells had in-
f 11 trated into the bursa of Fabricius, bronchial mucosa, and. 
s mall intestine. 
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DISCUSSION 
This study demonstrated that turkey poults which recover -
ed from experimental histomonosis infection as a result of 
drug therapy were refractory to the disease when challenged 
by the same infective agent. Administration of an i mmuno-
suppressant agent to immune recovered poults broke down this 
Tesistance and these birds succumbed to the disease when 
challenged. Parameters used in studying the host's responses 
to the disease included. mortality rates, weight gains, alter-
ations in hematologic and serum protein values, changes in 
SGOT activity l evels and histopathologic changes. 
Mortality Rates 
Fewer deaths were recorded in HN2 - treated groups of Trial 
III than in the corresponding groups in Trials I and II in 
which the disease was allowed to run its normal course. 
Based on the extent of tissue damage observed in some birds 
in Groups J and 4 of Trial III, it is believed that these 
birds would probably have died within the next 4 or 5 days. 
Weight Gains 
Throughout the trial period , observed weight gain de -
pressions were consistent with the reduction in feed and 
water consumption normally encountered in sick birds. 
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Hematologic Values 
Circulating leukocyte numbers were markedly increased. in 
all groups prior to treatment with dimetridazole primarily 
beca use of increased heterophil numbers although lymphocytes 
were also increased, particularly in Trial I . These findings 
are consistent with those of other workers (Johnson and Lange, 
1939; ~cGuire and Cavett, 1952). The increase in leukocyte 
numbers coincided with the appearance of sulfur-yellow 
droppings . This suggested that the disease had extended from 
the ceca to the liver and the marked leukocytosis was a re-
flection of increased tissue demand for heterophils brought 
about by the increasingly extensive tissue damage. The return 
of circulating leukocyte numbers to the normal range in all 
groups after the birds were treated with dimetridazole is 
similar to the pattern reported by Venkataratnam and Clarkson 
(1963) for chickens recovering from histomonosis infection . 
In the present study, the return of leukocyte numbers to 
normal levels was probably associated with the resolution of 
liver and cecal lesions as a result of drug therapy. 
The reduction of leukocyte numbers to levels below con-
trol values observed in birds which were being treated with 
nitrogen mustard (HN2) indicates that its cytotoxicity was 
effectively expressed in these trials . However , its anti -
leukem1c effect did not appear to be permanent since per-
ipheral leukocyte counts rose to values above control values 
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after the drug was withdrawn. 
The increase in total leukocyte numbers following chal-
lenge of HN2- treated and immune groups was a response to 
reinfection established by the challenging dose. Leukocy-
tosis whi ch deve l oped in some of the immune control birds 
was probably due t o relapse of the original infection. 
Relapses of this disease are not unusual because of the 
difficulty of completely eliminating all tissue histomonads . 
The lack of significant changes observed in eosinophil, 
basophil or monocyte counts, reflects the f indings of Male-
witz and Calhoun (1957). 
Serum Protein Changes 
The r eduction in serum albumin levels in all groups, 
12 to 15 days after infection, was similar to changes re-
ported by Clarkson (1959, 1966) . Clarkson attributed the 
fall in albumin to loss of large quantities of albumin into 
cecal lumen and to the inability of the damaged liver to 
produce adequate quantities of albumin . In the present 
study, albumin levels returned to normal after treatment 
with dimetridazole. This response pattern was similar to 
that r eported in chi ckens that were recovering from the dis-
ease by other investigators (Beg and Clarkson, 1970; McDougald 
and Hansen , 1969) and was associated with resolution of his -
tomonosis l esions. 
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The fall in albumin levels observed in HN2-treated birds, 
following challenge, correlated with the development of cecal 
and. liver lesions. Several factors may account for the rise 
in serum gamma globulins, observed between days 7 and 12 of 
infection. Precipitating antibodies which are produced in 
Histomonas-1nfected turkeys or chickens (Clarkson, 1963) 
appear in the gamma globulin fraction and are responsible, 
in part, for the rise in serum gamma globulins (Clarkson, 
1966). The rise may also be caused by the production of 
''non-specific immunoglobulins" by the ret1culoendothelial 
system in response to tissue destruction or to a decrease in 
osmotic pressure (Clarkson, 1966). Madden and Zeld.is (1958) 
have suggested that immunoglobulin-producing cells are pro-
bably stimulated by plasma amino acids which tend to accum-
ulate in the damaged liver. These workers also suggest that 
a decrease in albumin production may stimulate production of 
gamma globulins. Dougherty and. White (1946) suggested that 
the rate of release of gamma globulin from lymphocytes was 
under pituitary-ad.renal cortical control. They associated 
increase in serum gamma globulins with increased pituitary-
adrenal cortical secretions. It is difficult to say which, 
if any, of these factors are responsible for the rise in 
serum gamma globulins, in the present study. 
Changes in other globulin fractions were not very 
re~arkable and no reasonable expl anation can be advanced 
until nor mal netaboltc fates of these fractions have been 
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thoroughly worked out in the turkey. 
SGOT Values 
Results of SGOT studies were unexpected.. McDougald and 
Hansen (1970) found increases in GOT levels in Histomonas-
infected turkeys and chickens and. correlated these increases 
with tissue breakdown in the liver and ceca. Similar changes 
have been observed by this author in previous studies (Niyo, 
1970 unpublished) . However, ln the present study, there was 
a wide variation in enzyme level in each group from day to 
day. Serum enzyme levels lower than control values were 
sometimes observed in infected groups. Some of these birds 
were later found to have minimal liver lesions but had severe 
cecal lesions. Low transaminase levels have been reported in 
sera and tissues of pyrldoxine-deficient mammals (Sebrell and 
Harris , 1968 ) . It ls conceivable that alteration in cecal 
lumen , because of the extensive hlstomonosis lesions, might 
affect me tabolism of pyridoxine. Thi s may indirectly be 
reflected ln low transaminase activities which are dependent 
on this vitamin , but is not known whether similar mechanisms 
prevai l in avian species. I n any event, bird s in these 
trials did not show clinical signs referrable to pyridoxine 
deficiency . The large technical error inherent in this 
me thod of analysis and differences in rate of lesion develop-
~ent in individual birds may account for much of the varia-
176 
tions in enzyme levels observed in these trials . 
Histopathologic Studies 
The histologic response of immune birds to challenge 
with Histomonas- bearing Heterakis eggs consisted of extensive 
lymphocyt1c infiltration in all layers of the cecal wall . 
In addition, numerous well-circumscribed lymphoid foci were 
observed , primarily in the liver, ceca, and spleen. Similar 
lymphoid foci were occasionally found in other tissues. No 
h istomonads were observed in the tissues except in a few 
cases in which lesions were f ound in either the liver or the 
ceca . In contrast, HN2 - treated birds developed histomonosis 
lesions in the ceca and livers. Large numbers of histomonads 
were present in these tissues and were closely associated 
with giant cells and macrophages . Liver lesions had fewer 
infiltrating cells compared to normal birds, suggesting that 
there was a reduction in the cells associated with the pro-
tection of the host against the disease. I t is known that 
use of cytotoxic drugs in treatment of neoplastic diseases 
suppresses immune response of human patients and renders them 
susceptible to other infections (Schwartz and Borel , 1968) . 
In this study, two birds that had been treated with HN2 de-
veloped my cot1c ( g ranulomatous) pneumonia, probably as a 
result of drug- induced tolerance. 
The destruction of lymphoid cells of the spleen, bursa 
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of Fabricius and cecal tonsils observed in HN2-treated birds 
was attributed to the lymphocytotoxic action of the drug. 
Although histopathologic studies of the thymus were not 
carried out due to technical problems, the destruction of 
lymphocyte populations of this organ by the use of nitrogen 
mustard (HN2 ) has been reported (Kemp, 1970) . Depletion of 
follicular cells of the bursa of Fabricius was attributed to 
the action of HN2 rather than to the normal involution of 
this lympho-epithelial organ since no similar (regressive) 
changes were observed in either the i mmune-control or immune-
challenged birds which were of the same age and breed. 
Well circumscribed lymphoid foci, the bursa-dependent 
follicles, were prominent in immune-control and im.mune-
challenged birds but were absent in HN2-treated birds. These 
lymphoid foci are thought to constitute an important integral 
part of the lymphoid system in the chicken and probably in 
the turkey as well. They tend to enlarge in response to 
antigenic stimulus and consequently are prominent in certain 
avian diseases. Rhoades (1971 ) reported that they were prom-
inent in r eproductive tracts and air sacs of turkeys infected 
with Mycoplasma meleagridis and Taliaferro (1967) remarked on 
the increase of lymphoid nodules in avian malaria . It has 
been suggested that such nodules are related to the mechanism 
of immunity (Soulsby, 1967). 
Evidence for morphologic and functional similarity be-
tween bursal lymphocytes and the large lymphocytes of the 
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splenic germinal centers has been presented by several workers 
(Clawson et al ., 1967; Cooper et al . , 1965) . It has been 
pointed out that the function of the bursa- dependent system 
is the production of irnmunoglobulins (Cooper et al., 1967; 
Glick et al. ·, 1956; Jankovi6 and Mitrovic, 1967) . In the 
present study, serum-immunoglobulins were not greatly reduced 
in the HN2-treated groups despite the fact that there was a 
marked depletion of the bursa-dependent system. Some of these 
immunoglobulina may indeed be the serum precipitins described 
by Clarkson (1963) in Histomonas-infected turkeys or they 
may be non-specific immunoglobulins produced in response to 
catabolic by-products. 
Although immunoglobulin synthesis has been detected in 
bursaless chickens such birds are unable to produce anti-
bodies in response to antigenic stimulus (Cooper et al., 
1967). It is possible that total destruction of the bursa-
dependent cells was not accomplished so that the residual 
foci of these cells were still capable of producing these 
gamma globulins. In any event, these gamma globulins seem to 
provide little or no protection against histomonosis since 
infection was re-established in HN2- treated birds despite 
the presence of these globulins. Clarkson (1963) was unable 
to transfer solid protection from immune birds to susceptible 
birds by means of serum. Similar failures have been encounter-
ed with Besnoitia infections in hamsters (Frankel, 1967) . 
It has been stated that typical histomonosis lesions are 
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confined to the ceca and liver and there are indications that 
histomonads will infrequently invade other tissues such as 
spleen, kidney, and proventriculus (Johnson and Lange, 1939; 
Malewitz et al., 1958). In this study, histomonosis lesions 
were found in the kidneys of some HN2-treated birds. In 
addition, Histomonas-granulomas were found in the bursa of 
Fabricius of 2 birds that had. been treated. with HN2. In-
vasion of the bursa of Fabricius by histomonads has not been 
reported previously and while this may be a coincidental 
finding, it nevertheless leads one to some interesting spec-
ulations. Since these lesions were found in a st r ucture that 
is associated with antibody production, it was assumed that 
treatment with HN2 had suppressed immune responses of thi~ 
structure and rendered it susceptible to Hi stomonas invasion. 
Use of HN2 on recove r ed birds eliminated acquired re-
sistance so that they succumbed to challenge with histomonads 
introd.uced by Heterakis eggs. The severity of lesions was 
more pronounced in birds in which immunosuppression was 
started several days before challenge (Trial I) than in those 
birds in which the immunosuppressant agent was given together 
with or following challenge. This suggests that i mmunosup-
pression in this instance is best accomplished when nitrogen 
mustaT·d (HN2) administration is started before challenge. 
Loss of the acqui red resistance correlated with depletion of 
lymphoid cell population of the bursa of Fabricius , the spleen 
and cecal nodules and the disappearance of the bursa-depend-
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ent follicles which were quite pro~inent in the liver and 
ceca of the i mmune-challenged birds. It is tempting to 
speculate that acquired resistance to histomonosis is mediat-
ed by these residual lymphoid cells and that humoral factors 
probably play a minor protective role, i f any . It would be 
interesting to find out if transplantation of these cells 
from i mmune to susceptible birds can provide protective 
i mmunity to the disease. 
1 8 1 
CONCLUSIONS AND SUMMARY 
This study has produced a successful new model host/ 
parasite system for the study of cellular immune phenomena 
in protozoan diseases. It is superior to previous models 1n 
that the effects are well-defined, the host/parasite system 
ls a naturally occurring one, and the nature of the experi -
mental animals and parasites ls such that 1t is a convenient 
system to set up and a llows numerous easy experimental man-
ipulations to test various parameters of host/parasite inter-
action. 
The various hematologic and serologic values, while re-
flecting little response relative to the immune state of the 
hosts, nevertheless represent a more complete summary of 
values than have been collected heretofore in this host/ 
parasite system. 
Other specific findings from this study are summarized 
below: 
1. Mortality was higher and weight gain depressions 
were more pronounced in HN2-treated birds than in immune-
control or immune-challenged birds . 
2. Leukopenia obser ved in HN2-treated bird.a was not 
permanent and was attributed to the cytotoxic action of the 
drug on all rapid ly dividing cells . Following its withdrawal, 
these birds developed a marked leukocytos1s i n re sponse to 
challenging dose of virulent histomonads. 
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J. Changes observed in serum protein fractions were 
correlated with the development of histomonosis lesions. Ad-
ministration of HN2 did not appear to exert any significant 
effect on serum proteins. 
4. SGOT activity levels varied markedly among individual 
birds and the possible reasons for such patterns were dis-
cussed. 
5. Use of nitrogen mustard, HN2 , destroyed lymphoid 
follicles of the liver, spleen, and cecal necks. In addition, 
lymphoid cells of the bursa of Fabricius were also destroyed. 
Birds devoid of such cells were highly susceptible to 
Histomonas meleagrid.is infection. These birds developed 
severe cecal and liver lesions following challenge with 
virulent histomonads. This is the first time that acquired 
resistance to this disease has been eliminated by artificial 
means. In contrast, residual lymphoid cells were prominent 
in birds which had recovered from the disease but were not 
treated with HN2 . These birds were highly resistant to re-
infection. 
While results of this study are not completely defin-
itive, they nevertheless suggest that these residual lymphoid. 
cells are involved in mediation of acquired resistance to 
histomonosis infection. The major limitation of this study 
resides in the broad spectrum of immunosuppressive activity 
of mechlorethamine-HCl which prevented specif ic analysis of 
the roles of individual components of the reticulo-endothelial 
182b 
system. However, it is clearly indicated that acquired im-
munity to this disease can be suppressed, and selective 
ablative techniques such as bursectomy, splenectomy, t hymec-
tomy or combinations of such procedures, along with immuno-
cyte transplantation studies could well result in a definitive 
description of the immune phenomena operating in this condi -
tion. Such a result could be a significant addition to our 
und.erstanding of protozoan host/parasite relationships in 
other domestic animals, and perhaps man. 
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